// Regulatory agency types
export type RegulatoryAgency = 'FDA' | 'EMA' | 'PMDA' | 'NMPA' | 'MFDS' | 'HSA' | 'TGA';

export interface RegulatoryApproval {
  agency: RegulatoryAgency;
  status: 'approved' | 'pending' | 'not_approved' | 'withdrawn';
  approvalDate?: string;
  brandName?: string;
  indications?: string[];
  restrictions?: string[];
  riskCategory?: string;
  additionalWarnings?: string[];
}

export interface RegionalDosing {
  region: 'USA' | 'EU' | 'Japan' | 'China' | 'Korea' | 'Singapore' | 'Australia';
  adultDose: string;
  pediatricDose?: string;
  maxDose: string;
  notes?: string;
}

export interface MedicationData {
  name: string;
  genericName: string;
  brandNames: string[];
  category: string;
  form: string;
  strength: string;
  route: string;
  standardDoseAdult: string;
  standardDosePediatric?: string;
  maxDailyDose: string;
  dosingFrequency: string;
  weightBasedDosing: boolean;
  weightBasedFormula?: string;
  renalAdjustment?: string;
  hepaticAdjustment?: string;
  contraindications: string[];
  drugInteractions: string[];
  sideEffects: string[];
  blackBoxWarning?: string;
  pregnancyCategory: string;
  administrationNotes?: string;
  storageRequirements?: string;
  specialPrecautions?: string;
  monitoringParameters: string[];
  labsRequired: string[];
  isControlled: boolean;
  controlledSchedule?: string;
  // International regulatory approvals
  regulatoryApprovals?: RegulatoryApproval[];
  regionalDosing?: RegionalDosing[];
  regionalContraindications?: { region: string; contraindications: string[] }[];
  internationalBrandNames?: { region: string; names: string[] }[];
  riskEvaluationProgram?: string; // REMS (FDA), Risk Management Plan (EMA), etc.
  marketStatus?: 'active' | 'discontinued' | 'shortage' | 'limited';
}

export const medicationsDatabase: MedicationData[] = [
  // CARDIOVASCULAR MEDICATIONS
  {
    name: "Lisinopril",
    genericName: "Lisinopril",
    brandNames: ["Prinivil", "Zestril"],
    category: "Cardiovascular - ACE Inhibitor",
    form: "Tablet",
    strength: "2.5mg, 5mg, 10mg, 20mg, 40mg",
    route: "Oral",
    standardDoseAdult: "10-40mg once daily",
    standardDosePediatric: "0.07mg/kg once daily",
    maxDailyDose: "80mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: true,
    weightBasedFormula: "0.07mg/kg/day, max 0.6mg/kg/day",
    renalAdjustment: "CrCl 10-30: Start 2.5-5mg/day; CrCl <10: Start 2.5mg/day",
    hepaticAdjustment: "Use with caution in hepatic impairment",
    contraindications: ["History of angioedema", "Pregnancy", "Bilateral renal artery stenosis"],
    drugInteractions: ["Potassium supplements", "Potassium-sparing diuretics", "ARBs", "NSAIDs", "Lithium"],
    sideEffects: ["Dry cough", "Hyperkalemia", "Hypotension", "Dizziness", "Headache", "Fatigue"],
    blackBoxWarning: "Can cause fetal injury/death when used during pregnancy. Discontinue as soon as pregnancy is detected.",
    pregnancyCategory: "D",
    administrationNotes: "May be taken with or without food",
    storageRequirements: "Store at room temperature 20-25°C",
    monitoringParameters: ["Blood pressure", "Renal function", "Serum potassium"],
    labsRequired: ["BMP", "Potassium", "Creatinine"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1987-12-29", brandName: "Prinivil/Zestril", indications: ["Hypertension", "Heart Failure", "Post-MI"], riskCategory: "Pregnancy Category D" },
      { agency: "EMA", status: "approved", approvalDate: "1988-06-15", brandName: "Zestril", indications: ["Hypertension", "Heart Failure", "Diabetic Nephropathy"], restrictions: ["Contraindicated in pregnancy"] },
      { agency: "PMDA", status: "approved", approvalDate: "1990-09-01", brandName: "Longes", indications: ["Hypertension", "Chronic Heart Failure"], riskCategory: "Contraindicated in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1995-03-20", brandName: "力平之", indications: ["Hypertension", "Heart Failure"] },
      { agency: "MFDS", status: "approved", approvalDate: "1992-07-15", brandName: "제스트릴", indications: ["Hypertension", "Heart Failure", "Post-MI"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "10-40mg once daily", maxDose: "80mg/day", notes: "Start 5mg if on diuretics" },
      { region: "EU", adultDose: "10-20mg once daily", maxDose: "40mg/day", notes: "Lower starting dose in elderly" },
      { region: "Japan", adultDose: "5-20mg once daily", maxDose: "40mg/day", notes: "Generally lower doses due to body weight" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Longes", "ロンゲス"] },
      { region: "China", names: ["力平之", "利普妥"] },
      { region: "Korea", names: ["제스트릴", "Zestril"] },
      { region: "Germany", names: ["Acerbon", "Coric"] },
      { region: "Spain", names: ["Zestril", "Doneka"] }
    ]
  },
  {
    name: "Metoprolol Succinate",
    genericName: "Metoprolol Succinate",
    brandNames: ["Toprol-XL"],
    category: "Cardiovascular - Beta Blocker",
    form: "Extended-release tablet",
    strength: "25mg, 50mg, 100mg, 200mg",
    route: "Oral",
    standardDoseAdult: "25-200mg once daily",
    standardDosePediatric: "Not established",
    maxDailyDose: "400mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Reduce dose in severe hepatic impairment",
    contraindications: ["Severe bradycardia", "AV block", "Decompensated heart failure", "Cardiogenic shock"],
    drugInteractions: ["Verapamil", "Diltiazem", "Clonidine", "MAOIs", "Other beta blockers"],
    sideEffects: ["Bradycardia", "Fatigue", "Dizziness", "Depression", "Cold extremities"],
    pregnancyCategory: "C",
    administrationNotes: "Tablets may be divided but not crushed. Take with or immediately after meals.",
    monitoringParameters: ["Heart rate", "Blood pressure", "ECG"],
    labsRequired: ["None routinely"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1992-11-06", brandName: "Toprol-XL", indications: ["Hypertension", "Angina Pectoris", "Heart Failure"], riskCategory: "Pregnancy Category C" },
      { agency: "EMA", status: "approved", approvalDate: "1990-03-15", brandName: "Beloc-Zok", indications: ["Hypertension", "Angina", "Arrhythmia", "Heart Failure"] },
      { agency: "PMDA", status: "approved", approvalDate: "1983-09-20", brandName: "Seloken", indications: ["Hypertension", "Angina", "Tachyarrhythmia"], riskCategory: "Use with caution in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1995-06-10", brandName: "倍他乐克", indications: ["Hypertension", "Angina", "Heart Failure"] },
      { agency: "MFDS", status: "approved", approvalDate: "1991-04-25", brandName: "셀로켄", indications: ["Hypertension", "Angina", "Arrhythmia"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "25-200mg once daily", maxDose: "400mg/day", notes: "Start 25mg for heart failure" },
      { region: "EU", adultDose: "50-200mg once daily", maxDose: "400mg/day", notes: "Titrate based on heart rate response" },
      { region: "Japan", adultDose: "20-120mg once daily", maxDose: "240mg/day", notes: "Lower doses typical due to body weight differences" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Seloken", "セロケン"] },
      { region: "China", names: ["倍他乐克", "美托洛尔"] },
      { region: "Korea", names: ["셀로켄", "Seloken"] },
      { region: "Germany", names: ["Beloc-Zok", "Metoprolol-Succinat"] },
      { region: "Spain", names: ["Beloken", "Lopresor"] }
    ]
  },
  {
    name: "Amlodipine",
    genericName: "Amlodipine",
    brandNames: ["Norvasc"],
    category: "Cardiovascular - Calcium Channel Blocker",
    form: "Tablet",
    strength: "2.5mg, 5mg, 10mg",
    route: "Oral",
    standardDoseAdult: "5-10mg once daily",
    standardDosePediatric: "2.5-5mg once daily",
    maxDailyDose: "10mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Start 2.5mg in hepatic impairment",
    contraindications: ["Hypersensitivity to dihydropyridines", "Severe hypotension"],
    drugInteractions: ["CYP3A4 inhibitors", "Simvastatin", "Cyclosporine"],
    sideEffects: ["Peripheral edema", "Flushing", "Headache", "Dizziness", "Fatigue"],
    pregnancyCategory: "C",
    administrationNotes: "May be taken with or without food",
    monitoringParameters: ["Blood pressure", "Heart rate", "Peripheral edema"],
    labsRequired: ["None routinely"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1992-07-31", brandName: "Norvasc", indications: ["Hypertension", "Chronic Stable Angina", "Vasospastic Angina"], riskCategory: "Pregnancy Category C" },
      { agency: "EMA", status: "approved", approvalDate: "1990-09-10", brandName: "Norvasc", indications: ["Hypertension", "Angina Pectoris"], restrictions: ["Use with caution in pregnancy"] },
      { agency: "PMDA", status: "approved", approvalDate: "1993-03-25", brandName: "Norvasc/Amlodin", indications: ["Hypertension", "Angina Pectoris"], riskCategory: "Use with caution in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1996-05-15", brandName: "络活喜", indications: ["Hypertension", "Angina"] },
      { agency: "MFDS", status: "approved", approvalDate: "1994-02-20", brandName: "노바스크", indications: ["Hypertension", "Angina Pectoris"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "5-10mg once daily", maxDose: "10mg/day", notes: "Start 5mg; 2.5mg for small/frail patients" },
      { region: "EU", adultDose: "5-10mg once daily", maxDose: "10mg/day", notes: "Titrate over 1-2 weeks" },
      { region: "Japan", adultDose: "2.5-5mg once daily", maxDose: "10mg/day", notes: "Often start at 2.5mg due to body weight" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Norvasc", "ノルバスク", "Amlodin", "アムロジン"] },
      { region: "China", names: ["络活喜", "氨氯地平"] },
      { region: "Korea", names: ["노바스크", "Norvasc"] },
      { region: "Germany", names: ["Norvasc", "Amlodipin"] },
      { region: "Spain", names: ["Norvasc", "Astudal"] }
    ]
  },
  {
    name: "Atorvastatin",
    genericName: "Atorvastatin",
    brandNames: ["Lipitor"],
    category: "Cardiovascular - Statin",
    form: "Tablet",
    strength: "10mg, 20mg, 40mg, 80mg",
    route: "Oral",
    standardDoseAdult: "10-80mg once daily",
    standardDosePediatric: "10-20mg once daily (ages 10-17)",
    maxDailyDose: "80mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Contraindicated in active liver disease",
    contraindications: ["Active liver disease", "Pregnancy", "Breastfeeding", "Unexplained elevated transaminases"],
    drugInteractions: ["Gemfibrozil", "Niacin", "Cyclosporine", "CYP3A4 inhibitors", "Warfarin"],
    sideEffects: ["Myalgia", "Elevated transaminases", "Rhabdomyolysis", "Headache", "GI upset"],
    blackBoxWarning: "Rare cases of rhabdomyolysis with acute renal failure secondary to myoglobinuria.",
    pregnancyCategory: "X",
    administrationNotes: "May be taken at any time of day with or without food",
    monitoringParameters: ["LFTs", "Lipid panel", "CK if symptomatic"],
    labsRequired: ["Lipid panel", "LFTs", "A1c"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1996-12-17", brandName: "Lipitor", indications: ["Hyperlipidemia", "Primary Prevention of CVD", "Secondary Prevention of CVD"], riskCategory: "Pregnancy Category X" },
      { agency: "EMA", status: "approved", approvalDate: "1997-03-10", brandName: "Lipitor", indications: ["Hypercholesterolemia", "Prevention of Cardiovascular Events"], restrictions: ["Contraindicated in pregnancy"] },
      { agency: "PMDA", status: "approved", approvalDate: "2000-06-16", brandName: "Lipitor", indications: ["Hypercholesterolemia", "Familial Hypercholesterolemia"], riskCategory: "Contraindicated in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1999-09-20", brandName: "立普妥", indications: ["Hyperlipidemia", "Coronary Heart Disease Prevention"] },
      { agency: "MFDS", status: "approved", approvalDate: "1998-05-15", brandName: "리피토", indications: ["Hypercholesterolemia", "Mixed Dyslipidemia"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "10-80mg once daily", maxDose: "80mg/day", notes: "Start 10-20mg; 40-80mg for aggressive LDL reduction" },
      { region: "EU", adultDose: "10-80mg once daily", maxDose: "80mg/day", notes: "Individualize based on LDL goal" },
      { region: "Japan", adultDose: "5-20mg once daily", maxDose: "40mg/day", notes: "Lower doses effective in Asian populations" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Lipitor", "リピトール"] },
      { region: "China", names: ["立普妥", "阿托伐他汀"] },
      { region: "Korea", names: ["리피토", "Lipitor"] },
      { region: "Germany", names: ["Sortis", "Atorvastatin"] },
      { region: "Spain", names: ["Cardyl", "Lipitor"] }
    ]
  },
  {
    name: "Losartan",
    genericName: "Losartan",
    brandNames: ["Cozaar"],
    category: "Cardiovascular - ARB",
    form: "Tablet",
    strength: "25mg, 50mg, 100mg",
    route: "Oral",
    standardDoseAdult: "25-100mg once or twice daily",
    standardDosePediatric: "0.7mg/kg once daily (max 50mg)",
    maxDailyDose: "100mg",
    dosingFrequency: "Once or twice daily",
    weightBasedDosing: true,
    weightBasedFormula: "0.7mg/kg/day, max 1.4mg/kg/day",
    renalAdjustment: "Start lower dose in renal impairment",
    hepaticAdjustment: "Start 25mg in hepatic impairment",
    contraindications: ["Pregnancy", "History of angioedema with ARBs/ACEIs", "Concomitant aliskiren in diabetes"],
    drugInteractions: ["ACE inhibitors", "Potassium supplements", "Potassium-sparing diuretics", "NSAIDs", "Lithium"],
    sideEffects: ["Dizziness", "Hyperkalemia", "Hypotension", "Fatigue", "Diarrhea"],
    blackBoxWarning: "Can cause fetal injury/death when used during pregnancy.",
    pregnancyCategory: "D",
    administrationNotes: "May be taken with or without food",
    monitoringParameters: ["Blood pressure", "Renal function", "Serum potassium"],
    labsRequired: ["BMP", "Potassium", "Creatinine"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1995-04-14", brandName: "Cozaar", indications: ["Hypertension", "Diabetic Nephropathy", "Stroke Risk Reduction"], riskCategory: "Pregnancy Category D" },
      { agency: "EMA", status: "approved", approvalDate: "1994-06-09", brandName: "Cozaar", indications: ["Essential Hypertension", "Type 2 Diabetic Nephropathy", "Chronic Heart Failure"], restrictions: ["Contraindicated in pregnancy"] },
      { agency: "PMDA", status: "approved", approvalDate: "1998-06-30", brandName: "Nu-Lotan", indications: ["Hypertension", "Type 2 Diabetic Nephropathy"], riskCategory: "Contraindicated in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1998-11-15", brandName: "科素亚", indications: ["Hypertension", "Diabetic Nephropathy"] },
      { agency: "MFDS", status: "approved", approvalDate: "1997-03-20", brandName: "코자", indications: ["Hypertension", "Diabetic Nephropathy", "Heart Failure"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "25-100mg once or twice daily", maxDose: "100mg/day", notes: "Start 50mg; 25mg if volume depleted" },
      { region: "EU", adultDose: "50-100mg once daily", maxDose: "100mg/day", notes: "May divide into twice daily for better effect" },
      { region: "Japan", adultDose: "25-50mg once daily", maxDose: "100mg/day", notes: "Lower starting doses recommended" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Nu-Lotan", "ニューロタン"] },
      { region: "China", names: ["科素亚", "氯沙坦"] },
      { region: "Korea", names: ["코자", "Cozaar"] },
      { region: "Germany", names: ["Lorzaar", "Losartan"] },
      { region: "Spain", names: ["Cozaar", "Losartan"] }
    ]
  },
  {
    name: "Furosemide",
    genericName: "Furosemide",
    brandNames: ["Lasix"],
    category: "Cardiovascular - Loop Diuretic",
    form: "Tablet, Injection",
    strength: "20mg, 40mg, 80mg; IV: 10mg/mL",
    route: "Oral, IV",
    standardDoseAdult: "20-80mg once or twice daily",
    standardDosePediatric: "1-2mg/kg/dose",
    maxDailyDose: "600mg",
    dosingFrequency: "Once or twice daily",
    weightBasedDosing: true,
    weightBasedFormula: "1-2mg/kg/dose, max 6mg/kg/day",
    renalAdjustment: "Higher doses may be needed in renal impairment",
    hepaticAdjustment: "Use with caution; may precipitate hepatic coma",
    contraindications: ["Anuria", "Hepatic coma", "Severe electrolyte depletion"],
    drugInteractions: ["Aminoglycosides", "Cisplatin", "Digoxin", "Lithium", "NSAIDs"],
    sideEffects: ["Electrolyte imbalances", "Ototoxicity", "Dehydration", "Hypotension", "Hyperuricemia"],
    pregnancyCategory: "C",
    administrationNotes: "Take in morning to avoid nighttime diuresis. IV: Give slowly over 1-2 min",
    monitoringParameters: ["Electrolytes", "Renal function", "Blood pressure", "Weight"],
    labsRequired: ["BMP", "Magnesium", "Uric acid"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1966-07-22", brandName: "Lasix", indications: ["Edema", "Heart Failure", "Hypertension", "Acute Pulmonary Edema"], riskCategory: "Pregnancy Category C" },
      { agency: "EMA", status: "approved", approvalDate: "1964-03-15", brandName: "Lasix", indications: ["Edema", "Cardiac Failure", "Renal Failure", "Hepatic Cirrhosis"], restrictions: ["Use only if clearly needed in pregnancy"] },
      { agency: "PMDA", status: "approved", approvalDate: "1965-09-01", brandName: "Lasix", indications: ["Edema", "Heart Failure", "Renal Disease", "Hypertension"], riskCategory: "Use with caution in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1985-04-10", brandName: "速尿", indications: ["Edema", "Heart Failure", "Ascites"] },
      { agency: "MFDS", status: "approved", approvalDate: "1975-08-20", brandName: "라식스", indications: ["Edema", "Heart Failure", "Hypertension"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "20-80mg once or twice daily", maxDose: "600mg/day", notes: "May need higher doses in renal impairment" },
      { region: "EU", adultDose: "20-80mg/day", maxDose: "500mg/day", notes: "Start low and titrate; IV for acute situations" },
      { region: "Japan", adultDose: "20-40mg once or twice daily", maxDose: "250mg/day", notes: "Lower doses typically sufficient" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Lasix", "ラシックス"] },
      { region: "China", names: ["速尿", "呋塞米"] },
      { region: "Korea", names: ["라식스", "Lasix"] },
      { region: "Germany", names: ["Lasix", "Furosemid"] },
      { region: "Spain", names: ["Seguril", "Furosemida"] }
    ]
  },
  {
    name: "Hydrochlorothiazide",
    genericName: "Hydrochlorothiazide",
    brandNames: ["Microzide", "HydroDIURIL"],
    category: "Cardiovascular - Thiazide Diuretic",
    form: "Tablet, Capsule",
    strength: "12.5mg, 25mg, 50mg",
    route: "Oral",
    standardDoseAdult: "12.5-50mg once daily",
    standardDosePediatric: "1-2mg/kg/day",
    maxDailyDose: "100mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: true,
    weightBasedFormula: "1-2mg/kg/day",
    renalAdjustment: "Ineffective if CrCl <30; use loop diuretic instead",
    hepaticAdjustment: "Use with caution",
    contraindications: ["Anuria", "Sulfonamide allergy", "Severe renal impairment"],
    drugInteractions: ["Digoxin", "Lithium", "NSAIDs", "Corticosteroids"],
    sideEffects: ["Hypokalemia", "Hyponatremia", "Hyperuricemia", "Hyperglycemia", "Photosensitivity"],
    pregnancyCategory: "B",
    administrationNotes: "Take in morning to avoid nighttime diuresis",
    monitoringParameters: ["Electrolytes", "Renal function", "Blood pressure", "Blood glucose"],
    labsRequired: ["BMP", "Uric acid", "Lipid panel"],
    isControlled: false
  },
  {
    name: "Warfarin",
    genericName: "Warfarin Sodium",
    brandNames: ["Coumadin", "Jantoven"],
    category: "Cardiovascular - Anticoagulant",
    form: "Tablet",
    strength: "1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg, 6mg, 7.5mg, 10mg",
    route: "Oral",
    standardDoseAdult: "2-10mg once daily, adjusted by INR",
    maxDailyDose: "Individualized to INR",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No specific adjustment",
    hepaticAdjustment: "Use with caution; may require lower doses",
    contraindications: ["Active bleeding", "Hemorrhagic stroke", "Pregnancy", "Unsupervised patients"],
    drugInteractions: ["NSAIDs", "Aspirin", "Antibiotics", "Antifungals", "Vitamin K-containing foods"],
    sideEffects: ["Bleeding", "Bruising", "Purple toe syndrome", "Skin necrosis"],
    blackBoxWarning: "May cause major or fatal bleeding. Regular monitoring of INR required.",
    pregnancyCategory: "X",
    administrationNotes: "Take at same time each day. Maintain consistent vitamin K intake.",
    monitoringParameters: ["INR", "Signs of bleeding", "Hemoglobin"],
    labsRequired: ["INR", "PT", "CBC"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1954-06-08", brandName: "Coumadin", indications: ["Venous Thromboembolism", "Atrial Fibrillation", "Mechanical Heart Valves", "Post-MI"], riskCategory: "Pregnancy Category X" },
      { agency: "EMA", status: "approved", approvalDate: "1955-01-20", brandName: "Coumadin", indications: ["DVT/PE Prophylaxis", "Atrial Fibrillation", "Prosthetic Heart Valves"], restrictions: ["Contraindicated in pregnancy"] },
      { agency: "PMDA", status: "approved", approvalDate: "1962-04-15", brandName: "Warfarin", indications: ["Thromboembolism", "Atrial Fibrillation"], riskCategory: "Contraindicated in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1980-09-25", brandName: "华法林", indications: ["Thromboembolism", "Atrial Fibrillation", "Valve Replacement"] },
      { agency: "MFDS", status: "approved", approvalDate: "1970-12-10", brandName: "쿠마딘", indications: ["Venous Thromboembolism", "Atrial Fibrillation"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "2-10mg once daily", maxDose: "Individualized by INR", notes: "Target INR 2.0-3.0 for most indications" },
      { region: "EU", adultDose: "2-10mg once daily", maxDose: "Individualized by INR", notes: "Start 5mg; adjust based on INR" },
      { region: "Japan", adultDose: "1-5mg once daily", maxDose: "Individualized by INR", notes: "Lower doses needed; Asian patients more sensitive" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Warfarin", "ワーファリン"] },
      { region: "China", names: ["华法林", "华令"] },
      { region: "Korea", names: ["쿠마딘", "Coumadin"] },
      { region: "Germany", names: ["Marcumar", "Coumadin"] },
      { region: "Spain", names: ["Aldocumar", "Sintrom"] }
    ]
  },
  {
    name: "Clopidogrel",
    genericName: "Clopidogrel",
    brandNames: ["Plavix"],
    category: "Cardiovascular - Antiplatelet",
    form: "Tablet",
    strength: "75mg, 300mg",
    route: "Oral",
    standardDoseAdult: "75mg once daily; Loading: 300-600mg",
    maxDailyDose: "75mg maintenance",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Use with caution in severe hepatic impairment",
    contraindications: ["Active bleeding", "Severe hepatic impairment"],
    drugInteractions: ["Omeprazole", "Esomeprazole", "Warfarin", "NSAIDs"],
    sideEffects: ["Bleeding", "Bruising", "TTP", "GI upset", "Rash"],
    blackBoxWarning: "Reduced effectiveness in CYP2C19 poor metabolizers. Consider alternative therapy.",
    pregnancyCategory: "B",
    administrationNotes: "May be taken with or without food. Avoid with omeprazole.",
    monitoringParameters: ["Signs of bleeding", "CBC"],
    labsRequired: ["CBC", "Consider CYP2C19 genotyping"],
    isControlled: false
  },
  {
    name: "Digoxin",
    genericName: "Digoxin",
    brandNames: ["Lanoxin", "Digitek"],
    category: "Cardiovascular - Cardiac Glycoside",
    form: "Tablet, Injection",
    strength: "0.0625mg, 0.125mg, 0.25mg; IV: 0.25mg/mL",
    route: "Oral, IV",
    standardDoseAdult: "0.125-0.25mg once daily",
    standardDosePediatric: "10-15mcg/kg/day divided",
    maxDailyDose: "0.5mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: true,
    weightBasedFormula: "10-15mcg/kg/day",
    renalAdjustment: "Reduce dose significantly in renal impairment",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Ventricular fibrillation", "AV block", "Hypertrophic cardiomyopathy with obstruction"],
    drugInteractions: ["Amiodarone", "Verapamil", "Quinidine", "Diuretics", "Antacids"],
    sideEffects: ["Arrhythmias", "Nausea", "Vomiting", "Visual disturbances", "Confusion"],
    pregnancyCategory: "C",
    administrationNotes: "Monitor levels closely. Therapeutic range: 0.5-2.0 ng/mL",
    monitoringParameters: ["Digoxin level", "Electrolytes", "Renal function", "ECG"],
    labsRequired: ["Digoxin level", "BMP", "Magnesium"],
    isControlled: false
  },

  // DIABETES MEDICATIONS
  {
    name: "Metformin",
    genericName: "Metformin Hydrochloride",
    brandNames: ["Glucophage", "Glucophage XR", "Fortamet"],
    category: "Endocrine - Biguanide",
    form: "Tablet, Extended-release tablet",
    strength: "500mg, 850mg, 1000mg; ER: 500mg, 750mg, 1000mg",
    route: "Oral",
    standardDoseAdult: "500-1000mg twice daily with meals",
    standardDosePediatric: "500mg twice daily (ages 10+)",
    maxDailyDose: "2550mg (immediate), 2000mg (extended)",
    dosingFrequency: "Two to three times daily with meals",
    weightBasedDosing: false,
    renalAdjustment: "eGFR 30-45: Max 1000mg/day; eGFR <30: Contraindicated",
    hepaticAdjustment: "Avoid in hepatic impairment",
    contraindications: ["Renal impairment (eGFR <30)", "Metabolic acidosis", "Diabetic ketoacidosis"],
    drugInteractions: ["Iodinated contrast", "Alcohol", "Carbonic anhydrase inhibitors"],
    sideEffects: ["GI upset", "Diarrhea", "Vitamin B12 deficiency", "Lactic acidosis (rare)"],
    blackBoxWarning: "Lactic acidosis is a rare but serious metabolic complication.",
    pregnancyCategory: "B",
    administrationNotes: "Take with meals. Hold before contrast procedures.",
    monitoringParameters: ["A1c", "Renal function", "Vitamin B12"],
    labsRequired: ["A1c", "BMP", "B12"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1994-12-29", brandName: "Glucophage", indications: ["Type 2 Diabetes Mellitus"], riskCategory: "Pregnancy Category B" },
      { agency: "EMA", status: "approved", approvalDate: "1957-01-15", brandName: "Glucophage", indications: ["Type 2 Diabetes", "Pre-diabetes", "PCOS"], restrictions: ["Hold before contrast procedures"] },
      { agency: "PMDA", status: "approved", approvalDate: "1961-03-10", brandName: "Melbin", indications: ["Type 2 Diabetes Mellitus"], riskCategory: "Use with caution in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1999-05-20", brandName: "格华止", indications: ["Type 2 Diabetes", "Metabolic Syndrome"] },
      { agency: "MFDS", status: "approved", approvalDate: "1998-09-15", brandName: "글루코파지", indications: ["Type 2 Diabetes Mellitus"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "500-1000mg twice daily", maxDose: "2550mg/day", notes: "Start 500mg BID; titrate weekly" },
      { region: "EU", adultDose: "500-1000mg two to three times daily", maxDose: "3000mg/day", notes: "Higher max dose in EU" },
      { region: "Japan", adultDose: "250-500mg two to three times daily", maxDose: "2250mg/day", notes: "Lower starting doses recommended" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Melbin", "メルビン", "Glycoran", "グリコラン"] },
      { region: "China", names: ["格华止", "二甲双胍"] },
      { region: "Korea", names: ["글루코파지", "Glucophage"] },
      { region: "Germany", names: ["Siofor", "Glucophage"] },
      { region: "Spain", names: ["Dianben", "Metformina"] }
    ]
  },
  {
    name: "Glipizide",
    genericName: "Glipizide",
    brandNames: ["Glucotrol", "Glucotrol XL"],
    category: "Endocrine - Sulfonylurea",
    form: "Tablet, Extended-release tablet",
    strength: "5mg, 10mg; ER: 2.5mg, 5mg, 10mg",
    route: "Oral",
    standardDoseAdult: "5-10mg once or twice daily",
    maxDailyDose: "40mg",
    dosingFrequency: "Once or twice daily",
    weightBasedDosing: false,
    renalAdjustment: "Start with lower doses in renal impairment",
    hepaticAdjustment: "Reduce dose in hepatic impairment",
    contraindications: ["Type 1 diabetes", "Diabetic ketoacidosis", "Sulfonamide allergy"],
    drugInteractions: ["Beta blockers", "Fluoroquinolones", "Sulfonamides", "Alcohol"],
    sideEffects: ["Hypoglycemia", "Weight gain", "GI upset", "Photosensitivity"],
    pregnancyCategory: "C",
    administrationNotes: "Take 30 minutes before meals. ER: Take with breakfast.",
    monitoringParameters: ["Blood glucose", "A1c", "Signs of hypoglycemia"],
    labsRequired: ["A1c", "Fasting glucose"],
    isControlled: false
  },
  {
    name: "Insulin Glargine",
    genericName: "Insulin Glargine",
    brandNames: ["Lantus", "Basaglar", "Toujeo"],
    category: "Endocrine - Long-acting Insulin",
    form: "Injection",
    strength: "100 units/mL, 300 units/mL (Toujeo)",
    route: "Subcutaneous",
    standardDoseAdult: "10 units once daily, titrate to target",
    standardDosePediatric: "0.2-0.4 units/kg/day",
    maxDailyDose: "Individualized",
    dosingFrequency: "Once daily at same time",
    weightBasedDosing: true,
    weightBasedFormula: "0.2-0.4 units/kg/day starting, adjust to target",
    renalAdjustment: "May need reduced dose in renal impairment",
    hepaticAdjustment: "May need reduced dose in hepatic impairment",
    contraindications: ["Hypoglycemia", "Hypersensitivity to insulin"],
    drugInteractions: ["Beta blockers", "ACE inhibitors", "Thiazolidinediones"],
    sideEffects: ["Hypoglycemia", "Weight gain", "Lipodystrophy", "Injection site reactions"],
    pregnancyCategory: "C",
    administrationNotes: "Inject subcutaneously once daily. Do not mix with other insulins.",
    storageRequirements: "Refrigerate unopened. Room temp up to 28 days after opening.",
    monitoringParameters: ["Blood glucose", "A1c", "Signs of hypoglycemia"],
    labsRequired: ["A1c", "Fasting glucose", "BMP"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "2000-04-20", brandName: "Lantus", indications: ["Type 1 Diabetes", "Type 2 Diabetes"], riskCategory: "Pregnancy Category C" },
      { agency: "EMA", status: "approved", approvalDate: "2000-06-09", brandName: "Lantus", indications: ["Type 1 Diabetes", "Type 2 Diabetes"], restrictions: ["Monitor closely during pregnancy"] },
      { agency: "PMDA", status: "approved", approvalDate: "2003-10-16", brandName: "Lantus", indications: ["Diabetes Mellitus requiring insulin"], riskCategory: "Use with caution in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "2004-08-25", brandName: "来得时", indications: ["Type 1 Diabetes", "Type 2 Diabetes"] },
      { agency: "MFDS", status: "approved", approvalDate: "2003-06-20", brandName: "란투스", indications: ["Type 1 Diabetes", "Type 2 Diabetes"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "10 units once daily, titrate to target", maxDose: "Individualized", notes: "Titrate by 2 units every 3 days to FBG target" },
      { region: "EU", adultDose: "10 units once daily", maxDose: "Individualized", notes: "Adjust based on fasting glucose" },
      { region: "Japan", adultDose: "4-10 units once daily", maxDose: "Individualized", notes: "Often start lower due to insulin sensitivity" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Lantus", "ランタス"] },
      { region: "China", names: ["来得时", "甘精胰岛素"] },
      { region: "Korea", names: ["란투스", "Lantus"] },
      { region: "Germany", names: ["Lantus", "Toujeo"] },
      { region: "Spain", names: ["Lantus", "Toujeo"] }
    ]
  },
  {
    name: "Insulin Lispro",
    genericName: "Insulin Lispro",
    brandNames: ["Humalog", "Admelog"],
    category: "Endocrine - Rapid-acting Insulin",
    form: "Injection",
    strength: "100 units/mL",
    route: "Subcutaneous, IV",
    standardDoseAdult: "Based on carbohydrate intake and blood glucose",
    standardDosePediatric: "Based on carbohydrate intake and blood glucose",
    maxDailyDose: "Individualized",
    dosingFrequency: "With meals",
    weightBasedDosing: true,
    weightBasedFormula: "Total daily: 0.5-1 unit/kg; meal-time portion varies",
    renalAdjustment: "May need reduced dose in renal impairment",
    hepaticAdjustment: "May need reduced dose in hepatic impairment",
    contraindications: ["Hypoglycemia", "Hypersensitivity to insulin"],
    drugInteractions: ["Beta blockers", "ACE inhibitors", "Thiazolidinediones"],
    sideEffects: ["Hypoglycemia", "Weight gain", "Lipodystrophy", "Injection site reactions"],
    pregnancyCategory: "B",
    administrationNotes: "Inject within 15 minutes before or immediately after meals.",
    storageRequirements: "Refrigerate unopened. Room temp up to 28 days after opening.",
    monitoringParameters: ["Blood glucose", "A1c", "Signs of hypoglycemia"],
    labsRequired: ["A1c", "Pre/post-meal glucose", "BMP"],
    isControlled: false
  },
  {
    name: "Sitagliptin",
    genericName: "Sitagliptin",
    brandNames: ["Januvia"],
    category: "Endocrine - DPP-4 Inhibitor",
    form: "Tablet",
    strength: "25mg, 50mg, 100mg",
    route: "Oral",
    standardDoseAdult: "100mg once daily",
    maxDailyDose: "100mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "CrCl 30-50: 50mg/day; CrCl <30: 25mg/day",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Type 1 diabetes", "Diabetic ketoacidosis"],
    drugInteractions: ["Digoxin", "ACE inhibitors"],
    sideEffects: ["Upper respiratory infection", "Headache", "Pancreatitis (rare)"],
    pregnancyCategory: "B",
    administrationNotes: "May be taken with or without food",
    monitoringParameters: ["A1c", "Renal function", "Signs of pancreatitis"],
    labsRequired: ["A1c", "BMP", "Lipase if symptomatic"],
    isControlled: false
  },
  {
    name: "Empagliflozin",
    genericName: "Empagliflozin",
    brandNames: ["Jardiance"],
    category: "Endocrine - SGLT2 Inhibitor",
    form: "Tablet",
    strength: "10mg, 25mg",
    route: "Oral",
    standardDoseAdult: "10-25mg once daily",
    maxDailyDose: "25mg",
    dosingFrequency: "Once daily in morning",
    weightBasedDosing: false,
    renalAdjustment: "eGFR 30-45: 10mg/day; eGFR <30: Not recommended for glycemic control",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Type 1 diabetes", "Diabetic ketoacidosis", "Severe renal impairment for glycemic use"],
    drugInteractions: ["Diuretics", "Insulin", "Sulfonylureas"],
    sideEffects: ["UTI", "Genital mycotic infections", "Volume depletion", "Ketoacidosis"],
    pregnancyCategory: "C",
    administrationNotes: "Take in morning with or without food",
    monitoringParameters: ["A1c", "Renal function", "Blood pressure", "Signs of ketoacidosis"],
    labsRequired: ["A1c", "BMP", "Urinalysis"],
    isControlled: false
  },
  {
    name: "Liraglutide",
    genericName: "Liraglutide",
    brandNames: ["Victoza", "Saxenda"],
    category: "Endocrine - GLP-1 Receptor Agonist",
    form: "Injection",
    strength: "6mg/mL pen",
    route: "Subcutaneous",
    standardDoseAdult: "0.6mg daily x1 week, then 1.2-1.8mg daily",
    maxDailyDose: "1.8mg (Victoza), 3mg (Saxenda)",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "Use with caution; no dose adjustment",
    hepaticAdjustment: "Use with caution",
    contraindications: ["Personal/family history of MTC", "MEN 2 syndrome"],
    drugInteractions: ["Insulin", "Sulfonylureas", "Oral medications (delay absorption)"],
    sideEffects: ["Nausea", "Vomiting", "Diarrhea", "Pancreatitis", "Injection site reactions"],
    blackBoxWarning: "Risk of thyroid C-cell tumors in rodents. Unknown relevance to humans.",
    pregnancyCategory: "C",
    administrationNotes: "Inject subcutaneously in abdomen, thigh, or upper arm. Titrate slowly.",
    storageRequirements: "Refrigerate. Room temp for 30 days after first use.",
    monitoringParameters: ["A1c", "Weight", "Signs of pancreatitis", "Thyroid function"],
    labsRequired: ["A1c", "Lipase", "TSH"],
    isControlled: false
  },

  // ANTIBIOTICS
  {
    name: "Amoxicillin",
    genericName: "Amoxicillin",
    brandNames: ["Amoxil", "Trimox"],
    category: "Antibiotic - Penicillin",
    form: "Capsule, Tablet, Suspension",
    strength: "250mg, 500mg, 875mg; Susp: 125mg/5mL, 250mg/5mL",
    route: "Oral",
    standardDoseAdult: "250-500mg every 8 hours or 500-875mg every 12 hours",
    standardDosePediatric: "25-45mg/kg/day divided every 8-12 hours",
    maxDailyDose: "3000mg",
    dosingFrequency: "Every 8-12 hours",
    weightBasedDosing: true,
    weightBasedFormula: "25-45mg/kg/day divided every 8-12 hours",
    renalAdjustment: "CrCl 10-30: Max 500mg q12h; CrCl <10: Max 500mg q24h",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Penicillin allergy", "History of amoxicillin-related hepatic dysfunction"],
    drugInteractions: ["Probenecid", "Methotrexate", "Warfarin"],
    sideEffects: ["Diarrhea", "Nausea", "Rash", "Allergic reactions"],
    pregnancyCategory: "B",
    administrationNotes: "May be taken with or without food",
    monitoringParameters: ["Signs of allergic reaction", "Renal function with prolonged use"],
    labsRequired: ["BMP with prolonged use"],
    isControlled: false
  },
  {
    name: "Amoxicillin-Clavulanate",
    genericName: "Amoxicillin-Clavulanate",
    brandNames: ["Augmentin", "Augmentin ES"],
    category: "Antibiotic - Penicillin/Beta-lactamase Inhibitor",
    form: "Tablet, Suspension",
    strength: "250/125mg, 500/125mg, 875/125mg; XR: 1000/62.5mg",
    route: "Oral",
    standardDoseAdult: "500mg every 8 hours or 875mg every 12 hours",
    standardDosePediatric: "25-45mg/kg/day (amoxicillin component) divided every 8-12 hours",
    maxDailyDose: "4000mg amoxicillin",
    dosingFrequency: "Every 8-12 hours",
    weightBasedDosing: true,
    weightBasedFormula: "25-45mg/kg/day amoxicillin component",
    renalAdjustment: "CrCl <30: Do not use 875mg tablet; reduce dose",
    hepaticAdjustment: "Monitor LFTs; may cause cholestatic hepatitis",
    contraindications: ["Penicillin allergy", "Previous cholestatic jaundice/hepatic dysfunction"],
    drugInteractions: ["Probenecid", "Methotrexate", "Warfarin", "Oral contraceptives"],
    sideEffects: ["Diarrhea", "Nausea", "Vomiting", "Rash", "Hepatotoxicity"],
    pregnancyCategory: "B",
    administrationNotes: "Take with food to reduce GI upset. XR: Take with meal.",
    monitoringParameters: ["LFTs with prolonged use", "Signs of allergic reaction"],
    labsRequired: ["LFTs", "CBC"],
    isControlled: false
  },
  {
    name: "Azithromycin",
    genericName: "Azithromycin",
    brandNames: ["Zithromax", "Z-Pak"],
    category: "Antibiotic - Macrolide",
    form: "Tablet, Suspension, Injection",
    strength: "250mg, 500mg, 600mg; Susp: 100mg/5mL, 200mg/5mL; IV: 500mg",
    route: "Oral, IV",
    standardDoseAdult: "500mg day 1, then 250mg days 2-5; or 500mg daily x 3 days",
    standardDosePediatric: "10mg/kg day 1, then 5mg/kg days 2-5",
    maxDailyDose: "500mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: true,
    weightBasedFormula: "10mg/kg day 1, then 5mg/kg days 2-5",
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Use with caution in hepatic impairment",
    contraindications: ["Macrolide allergy", "History of cholestatic jaundice with azithromycin"],
    drugInteractions: ["QT-prolonging drugs", "Warfarin", "Digoxin", "Cyclosporine"],
    sideEffects: ["Diarrhea", "Nausea", "Abdominal pain", "QT prolongation", "Hepatotoxicity"],
    pregnancyCategory: "B",
    administrationNotes: "May take with or without food. Complete full course.",
    monitoringParameters: ["ECG if risk factors", "LFTs with prolonged use"],
    labsRequired: ["LFTs if symptomatic"],
    isControlled: false
  },
  {
    name: "Ciprofloxacin",
    genericName: "Ciprofloxacin",
    brandNames: ["Cipro", "Cipro XR"],
    category: "Antibiotic - Fluoroquinolone",
    form: "Tablet, Suspension, Injection",
    strength: "250mg, 500mg, 750mg; XR: 500mg, 1000mg; IV: 200mg/100mL, 400mg/200mL",
    route: "Oral, IV",
    standardDoseAdult: "250-750mg every 12 hours (oral); 200-400mg every 8-12 hours (IV)",
    standardDosePediatric: "10-20mg/kg/day divided every 12 hours (limited use)",
    maxDailyDose: "1500mg oral, 1200mg IV",
    dosingFrequency: "Every 12 hours",
    weightBasedDosing: true,
    weightBasedFormula: "10-20mg/kg/day divided every 12 hours",
    renalAdjustment: "CrCl 30-50: Reduce dose; CrCl <30: Give every 18-24 hours",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Fluoroquinolone allergy", "Tendon disorders", "Myasthenia gravis", "Children <18 years (relative)"],
    drugInteractions: ["Theophylline", "Warfarin", "Antacids", "Sucralfate", "Tizanidine"],
    sideEffects: ["Nausea", "Diarrhea", "Tendinitis/rupture", "QT prolongation", "CNS effects"],
    blackBoxWarning: "Risk of tendinitis and tendon rupture. Risk of peripheral neuropathy. May exacerbate myasthenia gravis.",
    pregnancyCategory: "C",
    administrationNotes: "Take 2 hours before or 6 hours after antacids/minerals. Hydrate well.",
    monitoringParameters: ["Tendon pain", "QT interval if risk factors", "Renal function"],
    labsRequired: ["BMP", "ECG if risk factors"],
    isControlled: false
  },
  {
    name: "Levofloxacin",
    genericName: "Levofloxacin",
    brandNames: ["Levaquin"],
    category: "Antibiotic - Fluoroquinolone",
    form: "Tablet, Injection",
    strength: "250mg, 500mg, 750mg; IV: 500mg/100mL, 750mg/150mL",
    route: "Oral, IV",
    standardDoseAdult: "250-750mg once daily",
    maxDailyDose: "750mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "CrCl 20-49: Adjust dose; CrCl <20: 500mg then 250mg q48h",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Fluoroquinolone allergy", "Tendon disorders", "Myasthenia gravis"],
    drugInteractions: ["Warfarin", "Antacids", "NSAIDs", "Corticosteroids", "QT-prolonging drugs"],
    sideEffects: ["Nausea", "Diarrhea", "Headache", "Tendinitis/rupture", "QT prolongation"],
    blackBoxWarning: "Risk of tendinitis and tendon rupture. Risk of peripheral neuropathy.",
    pregnancyCategory: "C",
    administrationNotes: "Take 2 hours before or 2 hours after antacids. Oral bioavailability equals IV.",
    monitoringParameters: ["Tendon pain", "QT interval if risk factors", "Blood glucose"],
    labsRequired: ["BMP", "Blood glucose"],
    isControlled: false
  },
  {
    name: "Doxycycline",
    genericName: "Doxycycline",
    brandNames: ["Vibramycin", "Doryx", "Oracea"],
    category: "Antibiotic - Tetracycline",
    form: "Capsule, Tablet, Suspension",
    strength: "50mg, 100mg; DR: 40mg, 50mg, 150mg",
    route: "Oral, IV",
    standardDoseAdult: "100mg every 12 hours or 200mg once daily",
    standardDosePediatric: "2.2mg/kg every 12 hours (>8 years old)",
    maxDailyDose: "200mg",
    dosingFrequency: "Once or twice daily",
    weightBasedDosing: true,
    weightBasedFormula: "2.2mg/kg every 12 hours, max 100mg/dose",
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Use with caution",
    contraindications: ["Tetracycline allergy", "Children <8 years (dental staining)", "Pregnancy"],
    drugInteractions: ["Antacids", "Iron", "Warfarin", "Oral contraceptives", "Barbiturates"],
    sideEffects: ["Photosensitivity", "GI upset", "Esophageal ulceration", "Dental discoloration"],
    pregnancyCategory: "D",
    administrationNotes: "Take with full glass of water. Remain upright 30 minutes after. Avoid sun.",
    monitoringParameters: ["Signs of photosensitivity", "GI tolerability"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Cephalexin",
    genericName: "Cephalexin",
    brandNames: ["Keflex"],
    category: "Antibiotic - Cephalosporin (1st gen)",
    form: "Capsule, Tablet, Suspension",
    strength: "250mg, 500mg, 750mg; Susp: 125mg/5mL, 250mg/5mL",
    route: "Oral",
    standardDoseAdult: "250-500mg every 6 hours",
    standardDosePediatric: "25-50mg/kg/day divided every 6-8 hours",
    maxDailyDose: "4000mg",
    dosingFrequency: "Every 6-12 hours",
    weightBasedDosing: true,
    weightBasedFormula: "25-50mg/kg/day divided every 6-8 hours",
    renalAdjustment: "CrCl 10-50: q8-12h; CrCl <10: q12-24h",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Cephalosporin allergy", "Severe penicillin allergy (10% cross-reactivity)"],
    drugInteractions: ["Probenecid", "Metformin", "Warfarin"],
    sideEffects: ["Diarrhea", "Nausea", "Rash", "Allergic reactions"],
    pregnancyCategory: "B",
    administrationNotes: "May be taken with or without food",
    monitoringParameters: ["Signs of allergic reaction", "Diarrhea"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Ceftriaxone",
    genericName: "Ceftriaxone",
    brandNames: ["Rocephin"],
    category: "Antibiotic - Cephalosporin (3rd gen)",
    form: "Injection",
    strength: "250mg, 500mg, 1g, 2g vials",
    route: "IV, IM",
    standardDoseAdult: "1-2g every 12-24 hours",
    standardDosePediatric: "50-100mg/kg/day divided every 12-24 hours",
    maxDailyDose: "4g",
    dosingFrequency: "Every 12-24 hours",
    weightBasedDosing: true,
    weightBasedFormula: "50-100mg/kg/day, max 4g/day",
    renalAdjustment: "No adjustment for renal impairment alone",
    hepaticAdjustment: "Max 2g/day in combined hepatic/renal impairment",
    contraindications: ["Cephalosporin allergy", "Neonates with hyperbilirubinemia", "Calcium-containing IV solutions in neonates"],
    drugInteractions: ["Calcium-containing products", "Warfarin"],
    sideEffects: ["Diarrhea", "Rash", "Biliary sludging", "Allergic reactions"],
    pregnancyCategory: "B",
    administrationNotes: "IV: Infuse over 30 minutes. Do not mix with calcium in same line.",
    monitoringParameters: ["Signs of allergic reaction", "LFTs with prolonged use"],
    labsRequired: ["LFTs", "CBC"],
    isControlled: false
  },
  {
    name: "Vancomycin",
    genericName: "Vancomycin",
    brandNames: ["Vancocin"],
    category: "Antibiotic - Glycopeptide",
    form: "Injection, Capsule (oral for C. diff)",
    strength: "IV: 500mg, 750mg, 1g, 1.5g vials; Oral: 125mg, 250mg capsules",
    route: "IV, Oral (C. diff only)",
    standardDoseAdult: "IV: 15-20mg/kg every 8-12 hours; Oral: 125mg every 6 hours",
    standardDosePediatric: "IV: 15mg/kg every 6 hours",
    maxDailyDose: "4g IV",
    dosingFrequency: "Every 6-12 hours",
    weightBasedDosing: true,
    weightBasedFormula: "15-20mg/kg/dose every 8-12 hours",
    renalAdjustment: "Significant adjustment needed based on CrCl",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Vancomycin allergy"],
    drugInteractions: ["Aminoglycosides", "NSAIDs", "Other nephrotoxic drugs"],
    sideEffects: ["Red man syndrome", "Nephrotoxicity", "Ototoxicity", "Phlebitis"],
    pregnancyCategory: "C",
    administrationNotes: "IV: Infuse over at least 60 minutes. Monitor levels.",
    monitoringParameters: ["Vancomycin levels (trough)", "Renal function", "CBC"],
    labsRequired: ["Vancomycin trough", "BMP", "CBC"],
    isControlled: false
  },
  {
    name: "Trimethoprim-Sulfamethoxazole",
    genericName: "Trimethoprim-Sulfamethoxazole",
    brandNames: ["Bactrim", "Bactrim DS", "Septra"],
    category: "Antibiotic - Sulfonamide",
    form: "Tablet, Suspension",
    strength: "SS: 80/400mg, DS: 160/800mg; Susp: 40/200mg per 5mL",
    route: "Oral, IV",
    standardDoseAdult: "DS 1 tablet every 12 hours; or 8-20mg/kg/day TMP divided",
    standardDosePediatric: "8-12mg/kg/day TMP divided every 12 hours",
    maxDailyDose: "320mg TMP/day (typical); higher for PCP",
    dosingFrequency: "Every 12 hours",
    weightBasedDosing: true,
    weightBasedFormula: "8-12mg/kg/day TMP component divided every 12 hours",
    renalAdjustment: "CrCl 15-30: 50% dose; CrCl <15: Avoid",
    hepaticAdjustment: "Use with caution",
    contraindications: ["Sulfonamide allergy", "Megaloblastic anemia", "G6PD deficiency", "Pregnancy at term"],
    drugInteractions: ["Warfarin", "Methotrexate", "Phenytoin", "ACE inhibitors"],
    sideEffects: ["Rash", "Nausea", "Hyperkalemia", "Bone marrow suppression", "Steven-Johnson syndrome"],
    pregnancyCategory: "D",
    administrationNotes: "Take with full glass of water. Maintain adequate hydration.",
    monitoringParameters: ["Potassium", "Renal function", "CBC", "Rash"],
    labsRequired: ["BMP", "CBC"],
    isControlled: false
  },

  // PAIN MEDICATIONS
  {
    name: "Acetaminophen",
    genericName: "Acetaminophen",
    brandNames: ["Tylenol", "Panadol"],
    category: "Analgesic/Antipyretic",
    form: "Tablet, Capsule, Liquid, Suppository",
    strength: "325mg, 500mg, 650mg; Liquid: 160mg/5mL; IV: 1000mg/100mL",
    route: "Oral, Rectal, IV",
    standardDoseAdult: "325-1000mg every 4-6 hours",
    standardDosePediatric: "10-15mg/kg every 4-6 hours",
    maxDailyDose: "4000mg (3000mg if liver disease or alcohol use)",
    dosingFrequency: "Every 4-6 hours as needed",
    weightBasedDosing: true,
    weightBasedFormula: "10-15mg/kg/dose, max 75mg/kg/day",
    renalAdjustment: "CrCl <10: Extend interval to every 8 hours",
    hepaticAdjustment: "Reduce dose; max 2g/day in chronic liver disease",
    contraindications: ["Severe hepatic impairment", "Acetaminophen allergy"],
    drugInteractions: ["Warfarin", "Alcohol", "Isoniazid", "Other hepatotoxic drugs"],
    sideEffects: ["Hepatotoxicity (overdose)", "Allergic reactions (rare)"],
    blackBoxWarning: "Contains acetaminophen. Severe liver damage may occur if more than 4g/day taken.",
    pregnancyCategory: "B",
    administrationNotes: "Check all medications for acetaminophen content to avoid overdose",
    monitoringParameters: ["LFTs with chronic use", "Signs of hepatotoxicity"],
    labsRequired: ["LFTs if prolonged use"],
    isControlled: false
  },
  {
    name: "Ibuprofen",
    genericName: "Ibuprofen",
    brandNames: ["Advil", "Motrin"],
    category: "Analgesic - NSAID",
    form: "Tablet, Capsule, Suspension",
    strength: "200mg, 400mg, 600mg, 800mg; Susp: 100mg/5mL",
    route: "Oral, IV",
    standardDoseAdult: "200-800mg every 6-8 hours",
    standardDosePediatric: "5-10mg/kg every 6-8 hours",
    maxDailyDose: "3200mg (Rx); 1200mg (OTC)",
    dosingFrequency: "Every 6-8 hours",
    weightBasedDosing: true,
    weightBasedFormula: "5-10mg/kg/dose every 6-8 hours",
    renalAdjustment: "Avoid in severe renal impairment",
    hepaticAdjustment: "Use with caution",
    contraindications: ["NSAID allergy", "Active GI bleeding", "Severe renal impairment", "CABG surgery"],
    drugInteractions: ["Aspirin", "Anticoagulants", "ACE inhibitors", "Diuretics", "Lithium"],
    sideEffects: ["GI upset", "GI bleeding", "Renal impairment", "Hypertension", "Cardiovascular events"],
    blackBoxWarning: "NSAIDs cause increased risk of serious cardiovascular and GI events.",
    pregnancyCategory: "C (D in 3rd trimester)",
    administrationNotes: "Take with food or milk to reduce GI upset",
    monitoringParameters: ["Renal function", "Blood pressure", "Signs of GI bleeding"],
    labsRequired: ["BMP with prolonged use"],
    isControlled: false
  },
  {
    name: "Naproxen",
    genericName: "Naproxen",
    brandNames: ["Aleve", "Naprosyn", "Anaprox"],
    category: "Analgesic - NSAID",
    form: "Tablet, Suspension",
    strength: "220mg, 250mg, 375mg, 500mg; DR: 375mg, 500mg",
    route: "Oral",
    standardDoseAdult: "250-500mg every 12 hours",
    standardDosePediatric: "5-7mg/kg every 8-12 hours",
    maxDailyDose: "1500mg initially, then 1000mg",
    dosingFrequency: "Every 8-12 hours",
    weightBasedDosing: true,
    weightBasedFormula: "5-7mg/kg/dose every 8-12 hours",
    renalAdjustment: "Avoid if CrCl <30",
    hepaticAdjustment: "Use with caution",
    contraindications: ["NSAID allergy", "Active GI bleeding", "Severe renal impairment", "CABG surgery"],
    drugInteractions: ["Aspirin", "Anticoagulants", "ACE inhibitors", "Diuretics", "Methotrexate"],
    sideEffects: ["GI upset", "GI bleeding", "Edema", "Dizziness", "Cardiovascular events"],
    blackBoxWarning: "NSAIDs cause increased risk of serious cardiovascular and GI events.",
    pregnancyCategory: "C (D in 3rd trimester)",
    administrationNotes: "Take with food or milk. DR tablets: swallow whole.",
    monitoringParameters: ["Renal function", "Blood pressure", "Signs of GI bleeding"],
    labsRequired: ["BMP with prolonged use"],
    isControlled: false
  },
  {
    name: "Oxycodone",
    genericName: "Oxycodone",
    brandNames: ["OxyContin", "Roxicodone"],
    category: "Analgesic - Opioid",
    form: "Tablet, Capsule, Solution, Extended-release tablet",
    strength: "5mg, 10mg, 15mg, 20mg, 30mg; ER: 10mg-80mg",
    route: "Oral",
    standardDoseAdult: "IR: 5-15mg every 4-6 hours; ER: Per opioid tolerance",
    maxDailyDose: "No ceiling, but titrate carefully",
    dosingFrequency: "IR: Every 4-6 hours; ER: Every 12 hours",
    weightBasedDosing: false,
    renalAdjustment: "Start with 25-50% of normal dose",
    hepaticAdjustment: "Start with 33-50% of normal dose",
    contraindications: ["Opioid allergy", "Respiratory depression", "Paralytic ileus", "MAOIs within 14 days"],
    drugInteractions: ["CNS depressants", "Benzodiazepines", "CYP3A4 inhibitors", "MAOIs"],
    sideEffects: ["Constipation", "Nausea", "Sedation", "Respiratory depression", "Physical dependence"],
    blackBoxWarning: "Risk of addiction, abuse, and misuse. Risk of life-threatening respiratory depression. Concomitant use with benzodiazepines may result in death.",
    pregnancyCategory: "C (D with prolonged use)",
    administrationNotes: "ER: Swallow whole, do not crush, chew, or dissolve. Use stool softeners.",
    monitoringParameters: ["Pain level", "Respiratory status", "Sedation level", "Bowel function"],
    labsRequired: ["Consider baseline LFTs"],
    isControlled: true,
    controlledSchedule: "Schedule II"
  },
  {
    name: "Hydrocodone/Acetaminophen",
    genericName: "Hydrocodone Bitartrate/Acetaminophen",
    brandNames: ["Vicodin", "Norco", "Lortab"],
    category: "Analgesic - Opioid Combination",
    form: "Tablet, Solution",
    strength: "5mg/325mg, 7.5mg/325mg, 10mg/325mg",
    route: "Oral",
    standardDoseAdult: "5-10mg hydrocodone every 4-6 hours as needed",
    standardDosePediatric: "Not recommended for pediatric use",
    maxDailyDose: "Maximum 4g acetaminophen/day",
    dosingFrequency: "Every 4-6 hours as needed",
    weightBasedDosing: false,
    renalAdjustment: "Use with caution; reduce dose in severe impairment",
    hepaticAdjustment: "Avoid or reduce dose; acetaminophen hepatotoxicity risk",
    contraindications: ["Opioid allergy", "Acetaminophen allergy", "Respiratory depression", "Severe hepatic impairment", "MAOIs within 14 days"],
    drugInteractions: ["CNS depressants", "Benzodiazepines", "Alcohol", "CYP3A4 inhibitors", "MAOIs", "Other acetaminophen products"],
    sideEffects: ["Constipation", "Nausea", "Sedation", "Dizziness", "Respiratory depression", "Hepatotoxicity"],
    blackBoxWarning: "Risk of addiction, abuse, and misuse. Risk of life-threatening respiratory depression. Acetaminophen has been associated with acute liver failure, at times resulting in liver transplant and death.",
    pregnancyCategory: "C (D with prolonged use)",
    administrationNotes: "Take with or without food. Monitor total acetaminophen intake from all sources. Use stool softeners.",
    monitoringParameters: ["Pain level", "Respiratory status", "Liver function", "Total acetaminophen intake"],
    labsRequired: ["LFTs periodically"],
    isControlled: true,
    controlledSchedule: "Schedule II",
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1983-02-14", brandName: "Vicodin", indications: ["Moderate to Moderately Severe Pain"], riskCategory: "Pregnancy Category C/D", additionalWarnings: ["Maximum 4g acetaminophen/day", "High abuse potential"] },
      { agency: "EMA", status: "restricted", approvalDate: "1990-06-20", brandName: "Not widely marketed", indications: ["Pain Management"], restrictions: ["Limited availability in EU due to opioid combination concerns"] },
      { agency: "PMDA", status: "approved", approvalDate: "2011-01-21", brandName: "Norspan", indications: ["Moderate to Severe Pain"], riskCategory: "Narcotics control", additionalWarnings: ["Strict dispensing regulations"] },
      { agency: "NMPA", status: "restricted", approvalDate: "2005-08-15", brandName: "氢可酮/对乙酰氨基酚", indications: ["Severe Pain"], restrictions: ["Limited to hospital use"] },
      { agency: "MFDS", status: "restricted", approvalDate: "2008-03-10", brandName: "하이드로코돈/아세트아미노펜", indications: ["Moderate to Severe Pain"], restrictions: ["Controlled distribution"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "5-10mg hydrocodone q4-6h", maxDose: "Max 4g acetaminophen/day", notes: "Most commonly prescribed opioid in US; watch acetaminophen limits" },
      { region: "EU", adultDose: "Not widely used", maxDose: "Alternative opioids preferred", notes: "Combination not commonly marketed in EU" },
      { region: "Japan", adultDose: "2.5-5mg hydrocodone equivalent q6h", maxDose: "Strict limits", notes: "Lower doses; strict narcotic controls" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["ノルスパン", "Norspan"] },
      { region: "China", names: ["氢可酮/对乙酰氨基酚", "复方氢可酮"] },
      { region: "Korea", names: ["하이드로코돈정", "Hydrocodone"] },
      { region: "Germany", names: ["Hydrocodon", "Dihydrocodein"] },
      { region: "USA", names: ["Vicodin", "Norco", "Lortab"] }
    ],
    riskEvaluationProgram: "FDA opioid REMS required"
  },
  {
    name: "Morphine",
    genericName: "Morphine Sulfate",
    brandNames: ["MS Contin", "Kadian", "Roxanol"],
    category: "Analgesic - Opioid",
    form: "Tablet, Capsule, Solution, Extended-release, Injection",
    strength: "IR: 15mg, 30mg; ER: 15mg-200mg; IV: 2-15mg/mL",
    route: "Oral, IV, IM, SC, Epidural",
    standardDoseAdult: "IR: 10-30mg every 4 hours; IV: 2-10mg every 2-4 hours",
    standardDosePediatric: "0.1-0.2mg/kg every 4 hours",
    maxDailyDose: "No ceiling, but titrate carefully",
    dosingFrequency: "IR: Every 4 hours; ER: Every 8-12 or 24 hours",
    weightBasedDosing: true,
    weightBasedFormula: "0.1-0.2mg/kg/dose",
    renalAdjustment: "Reduce dose 25-75% based on CrCl",
    hepaticAdjustment: "Reduce dose significantly",
    contraindications: ["Opioid allergy", "Respiratory depression", "Paralytic ileus", "MAOIs within 14 days"],
    drugInteractions: ["CNS depressants", "Benzodiazepines", "MAOIs", "Anticholinergics"],
    sideEffects: ["Constipation", "Nausea", "Sedation", "Respiratory depression", "Hypotension", "Urinary retention"],
    blackBoxWarning: "Risk of addiction, abuse, and misuse. Risk of life-threatening respiratory depression.",
    pregnancyCategory: "C (D with prolonged use)",
    administrationNotes: "ER formulations should not be crushed. IV: Give slowly.",
    monitoringParameters: ["Pain level", "Respiratory status", "Blood pressure", "Bowel function"],
    labsRequired: ["None routinely"],
    isControlled: true,
    controlledSchedule: "Schedule II",
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1941-05-01", brandName: "Morphine Sulfate", indications: ["Severe Pain", "Post-surgical Pain", "Cancer Pain"], riskCategory: "Pregnancy Category C/D", additionalWarnings: ["REMS required", "High abuse potential"] },
      { agency: "EMA", status: "approved", approvalDate: "1950-01-15", brandName: "MST Continus", indications: ["Severe Pain", "Cancer Pain", "Palliative Care"], restrictions: ["Controlled substance", "Prescription monitoring required"] },
      { agency: "PMDA", status: "approved", approvalDate: "1952-08-20", brandName: "MS Contin", indications: ["Severe Pain", "Cancer Pain"], riskCategory: "Narcotics control", additionalWarnings: ["Strict dispensing regulations"] },
      { agency: "NMPA", status: "approved", approvalDate: "1985-06-10", brandName: "吗啡", indications: ["Severe Pain", "Cancer Pain"] },
      { agency: "MFDS", status: "approved", approvalDate: "1975-03-25", brandName: "모르핀", indications: ["Severe Pain", "Cancer Pain", "Post-surgical Pain"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "IR: 10-30mg q4h; IV: 2-10mg q2-4h", maxDose: "No ceiling, titrate carefully", notes: "Opioid-naive: start low" },
      { region: "EU", adultDose: "IR: 5-20mg q4h", maxDose: "Individualized", notes: "Lower starting doses recommended" },
      { region: "Japan", adultDose: "IR: 5-10mg q4-6h", maxDose: "Individualized", notes: "Lower doses due to body weight; strict regulations" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["MS Contin", "MSコンチン", "Optiso", "オプソ"] },
      { region: "China", names: ["吗啡", "美施康定"] },
      { region: "Korea", names: ["모르핀", "MS Contin"] },
      { region: "Germany", names: ["MST", "Capros"] },
      { region: "Spain", names: ["Sevredol", "MST Continus"] }
    ],
    riskEvaluationProgram: "FDA REMS required for extended-release formulations"
  },
  {
    name: "Gabapentin",
    genericName: "Gabapentin",
    brandNames: ["Neurontin", "Gralise"],
    category: "Analgesic - Anticonvulsant",
    form: "Capsule, Tablet, Solution",
    strength: "100mg, 300mg, 400mg, 600mg, 800mg",
    route: "Oral",
    standardDoseAdult: "300mg TID, titrate to 1800-3600mg/day",
    standardDosePediatric: "10-15mg/kg/day divided TID",
    maxDailyDose: "3600mg",
    dosingFrequency: "Three times daily",
    weightBasedDosing: true,
    weightBasedFormula: "10-15mg/kg/day divided TID",
    renalAdjustment: "CrCl 30-59: Max 1400mg/day; CrCl 15-29: Max 700mg/day; CrCl <15: Max 300mg/day",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Hypersensitivity to gabapentin"],
    drugInteractions: ["Antacids", "Opioids", "CNS depressants"],
    sideEffects: ["Dizziness", "Somnolence", "Peripheral edema", "Ataxia", "Weight gain"],
    blackBoxWarning: "Increased risk of suicidal thoughts or behavior.",
    pregnancyCategory: "C",
    administrationNotes: "May be taken with or without food. Taper to discontinue.",
    monitoringParameters: ["Pain level", "Mood/suicidal ideation", "Renal function"],
    labsRequired: ["BMP"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1993-12-30", brandName: "Neurontin", indications: ["Epilepsy", "Postherpetic Neuralgia"], riskCategory: "Pregnancy Category C" },
      { agency: "EMA", status: "approved", approvalDate: "1995-05-26", brandName: "Neurontin", indications: ["Epilepsy", "Peripheral Neuropathic Pain"], restrictions: ["Monitor for suicidal ideation"] },
      { agency: "PMDA", status: "approved", approvalDate: "2006-07-21", brandName: "Gabapen", indications: ["Epilepsy", "Neuropathic Pain"], riskCategory: "Use with caution in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1999-10-15", brandName: "加巴喷丁", indications: ["Epilepsy", "Neuropathic Pain"] },
      { agency: "MFDS", status: "approved", approvalDate: "1998-04-20", brandName: "뉴론틴", indications: ["Epilepsy", "Neuropathic Pain", "Postherpetic Neuralgia"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "300mg TID, titrate to 1800-3600mg/day", maxDose: "3600mg/day", notes: "Start 300mg on day 1, titrate up" },
      { region: "EU", adultDose: "300-600mg TID", maxDose: "3600mg/day", notes: "Titrate over 3 days minimum" },
      { region: "Japan", adultDose: "200-400mg TID", maxDose: "2400mg/day", notes: "Lower max doses typically used" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Gabapen", "ガバペン"] },
      { region: "China", names: ["加巴喷丁", "诺必达"] },
      { region: "Korea", names: ["뉴론틴", "Neurontin"] },
      { region: "Germany", names: ["Neurontin", "Gabapentin"] },
      { region: "Spain", names: ["Neurontin", "Gabapentina"] }
    ]
  },
  {
    name: "Pregabalin",
    genericName: "Pregabalin",
    brandNames: ["Lyrica"],
    category: "Analgesic - Anticonvulsant",
    form: "Capsule, Solution",
    strength: "25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg",
    route: "Oral",
    standardDoseAdult: "150-600mg/day divided BID-TID",
    maxDailyDose: "600mg",
    dosingFrequency: "Two to three times daily",
    weightBasedDosing: false,
    renalAdjustment: "CrCl 30-60: Max 300mg/day; CrCl 15-30: Max 150mg/day; CrCl <15: Max 75mg/day",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Hypersensitivity to pregabalin"],
    drugInteractions: ["Opioids", "CNS depressants", "ACE inhibitors", "Thiazolidinediones"],
    sideEffects: ["Dizziness", "Somnolence", "Weight gain", "Peripheral edema", "Blurred vision"],
    blackBoxWarning: "Increased risk of suicidal thoughts or behavior.",
    pregnancyCategory: "C",
    administrationNotes: "May be taken with or without food. Taper to discontinue.",
    monitoringParameters: ["Pain level", "Mood/suicidal ideation", "Renal function", "Weight"],
    labsRequired: ["BMP", "CPK if muscle symptoms"],
    isControlled: true,
    controlledSchedule: "Schedule V"
  },

  // RESPIRATORY MEDICATIONS
  {
    name: "Albuterol",
    genericName: "Albuterol Sulfate",
    brandNames: ["ProAir", "Ventolin", "Proventil"],
    category: "Respiratory - Beta-2 Agonist",
    form: "MDI, Nebulizer solution, Tablet",
    strength: "MDI: 90mcg/puff; Neb: 0.083%, 0.5%; Tab: 2mg, 4mg",
    route: "Inhalation, Oral",
    standardDoseAdult: "MDI: 2 puffs every 4-6 hours; Neb: 2.5mg every 4-6 hours",
    standardDosePediatric: "MDI: 1-2 puffs every 4-6 hours; Neb: 0.1-0.15mg/kg every 4-6 hours",
    maxDailyDose: "MDI: 12 puffs/day; Neb: 15mg",
    dosingFrequency: "Every 4-6 hours as needed",
    weightBasedDosing: true,
    weightBasedFormula: "0.1-0.15mg/kg/dose nebulized",
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Hypersensitivity to albuterol or milk proteins"],
    drugInteractions: ["Beta blockers", "MAOIs", "TCAs", "Digoxin"],
    sideEffects: ["Tachycardia", "Tremor", "Palpitations", "Nervousness", "Hypokalemia"],
    pregnancyCategory: "C",
    administrationNotes: "Shake MDI well before use. Rinse mouth after use.",
    monitoringParameters: ["Heart rate", "Respiratory status", "Potassium"],
    labsRequired: ["Potassium with frequent use"],
    isControlled: false
  },
  {
    name: "Fluticasone Propionate",
    genericName: "Fluticasone Propionate",
    brandNames: ["Flovent HFA", "Flovent Diskus"],
    category: "Respiratory - Inhaled Corticosteroid",
    form: "MDI, Diskus",
    strength: "HFA: 44mcg, 110mcg, 220mcg; Diskus: 50mcg, 100mcg, 250mcg",
    route: "Inhalation",
    standardDoseAdult: "88-440mcg twice daily",
    standardDosePediatric: "88-176mcg twice daily (ages 4-11)",
    maxDailyDose: "880mcg",
    dosingFrequency: "Twice daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Use with caution",
    contraindications: ["Primary treatment of status asthmaticus", "Hypersensitivity to fluticasone"],
    drugInteractions: ["Ritonavir", "Ketoconazole", "Other CYP3A4 inhibitors"],
    sideEffects: ["Oral candidiasis", "Hoarseness", "Pharyngitis", "Headache"],
    pregnancyCategory: "C",
    administrationNotes: "Rinse mouth after use. Not for acute bronchospasm.",
    monitoringParameters: ["Peak flow", "Symptom control", "Growth in children"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Montelukast",
    genericName: "Montelukast Sodium",
    brandNames: ["Singulair"],
    category: "Respiratory - Leukotriene Receptor Antagonist",
    form: "Tablet, Chewable tablet, Granules",
    strength: "10mg, Chewable: 4mg, 5mg; Granules: 4mg",
    route: "Oral",
    standardDoseAdult: "10mg once daily in evening",
    standardDosePediatric: "4mg (2-5 years), 5mg (6-14 years) once daily in evening",
    maxDailyDose: "10mg",
    dosingFrequency: "Once daily in evening",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "No adjustment needed for mild-moderate",
    contraindications: ["Hypersensitivity to montelukast"],
    drugInteractions: ["Phenobarbital", "Rifampin"],
    sideEffects: ["Headache", "Abdominal pain", "Behavioral changes", "Upper respiratory infection"],
    blackBoxWarning: "Serious neuropsychiatric events reported including suicidal thinking and behavior.",
    pregnancyCategory: "B",
    administrationNotes: "Take in evening. Granules can be mixed with food.",
    monitoringParameters: ["Asthma symptoms", "Neuropsychiatric symptoms"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Prednisone",
    genericName: "Prednisone",
    brandNames: ["Deltasone", "Rayos"],
    category: "Respiratory/Anti-inflammatory - Corticosteroid",
    form: "Tablet, Solution",
    strength: "1mg, 2.5mg, 5mg, 10mg, 20mg, 50mg",
    route: "Oral",
    standardDoseAdult: "40-60mg/day for 5-10 days (asthma exacerbation)",
    standardDosePediatric: "1-2mg/kg/day (max 60mg) for 3-10 days",
    maxDailyDose: "80mg acute; varies for chronic",
    dosingFrequency: "Once daily or divided",
    weightBasedDosing: true,
    weightBasedFormula: "1-2mg/kg/day, max 60mg/day",
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Active prednisone; may need higher doses",
    contraindications: ["Systemic fungal infections", "Live vaccines during high-dose therapy"],
    drugInteractions: ["NSAIDs", "Warfarin", "Diuretics", "Vaccines", "Antidiabetics"],
    sideEffects: ["Hyperglycemia", "Insomnia", "Mood changes", "Weight gain", "Osteoporosis"],
    pregnancyCategory: "C",
    administrationNotes: "Take with food. Taper if used >2 weeks. Give in morning if once daily.",
    monitoringParameters: ["Blood glucose", "Blood pressure", "Weight", "Bone density (long-term)"],
    labsRequired: ["Blood glucose", "Electrolytes"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1955-02-21", brandName: "Deltasone", indications: ["Inflammatory Conditions", "Allergic Reactions", "Autoimmune Disorders", "Asthma"], riskCategory: "Pregnancy Category C" },
      { agency: "EMA", status: "approved", approvalDate: "1955-06-10", brandName: "Decortin", indications: ["Inflammatory Diseases", "Allergic Conditions", "Rheumatic Disorders"] },
      { agency: "PMDA", status: "approved", approvalDate: "1956-03-15", brandName: "Predonine", indications: ["Inflammatory Diseases", "Allergic Disorders", "Autoimmune Conditions"], riskCategory: "Use with caution in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1980-08-20", brandName: "强的松", indications: ["Inflammatory Conditions", "Allergic Reactions", "Autoimmune Disorders"] },
      { agency: "MFDS", status: "approved", approvalDate: "1970-11-15", brandName: "프레드니손", indications: ["Inflammatory Diseases", "Allergic Conditions"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "40-60mg/day for acute; 5-10mg/day maintenance", maxDose: "80mg/day acute", notes: "Morning dosing preferred; taper after prolonged use" },
      { region: "EU", adultDose: "30-60mg/day for acute conditions", maxDose: "100mg/day", notes: "Gradual tapering essential" },
      { region: "Japan", adultDose: "20-60mg/day for acute; 5-10mg/day maintenance", maxDose: "60mg/day", notes: "Lower doses often effective in Asian patients" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Predonine", "プレドニン"] },
      { region: "China", names: ["强的松", "泼尼松"] },
      { region: "Korea", names: ["프레드니손", "Prednisone"] },
      { region: "Germany", names: ["Decortin", "Prednisolon"] },
      { region: "Spain", names: ["Dacortin", "Prednisona"] }
    ]
  },

  // GI MEDICATIONS
  {
    name: "Omeprazole",
    genericName: "Omeprazole",
    brandNames: ["Prilosec"],
    category: "GI - Proton Pump Inhibitor",
    form: "Capsule, ODT, Suspension",
    strength: "10mg, 20mg, 40mg",
    route: "Oral",
    standardDoseAdult: "20-40mg once daily",
    standardDosePediatric: "0.7-3.3mg/kg/day once daily",
    maxDailyDose: "40mg",
    dosingFrequency: "Once daily before breakfast",
    weightBasedDosing: true,
    weightBasedFormula: "0.7-3.3mg/kg/day, max 40mg/day",
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Max 20mg/day in hepatic impairment",
    contraindications: ["Hypersensitivity to PPIs", "Concomitant rilpivirine"],
    drugInteractions: ["Clopidogrel", "Methotrexate", "Digoxin", "Warfarin", "HIV medications"],
    sideEffects: ["Headache", "Diarrhea", "C. diff infection", "Bone fractures", "Vitamin B12 deficiency"],
    pregnancyCategory: "C",
    administrationNotes: "Take 30-60 minutes before eating. Swallow capsules whole.",
    monitoringParameters: ["Symptom relief", "Magnesium (long-term)", "B12 (long-term)"],
    labsRequired: ["Magnesium with long-term use"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1989-09-14", brandName: "Prilosec", indications: ["GERD", "Erosive Esophagitis", "H. pylori Eradication", "Zollinger-Ellison Syndrome"], riskCategory: "Pregnancy Category C" },
      { agency: "EMA", status: "approved", approvalDate: "1988-04-05", brandName: "Losec", indications: ["GERD", "Peptic Ulcer", "H. pylori Eradication"], restrictions: ["Long-term use requires monitoring"] },
      { agency: "PMDA", status: "approved", approvalDate: "1991-09-27", brandName: "Omepral", indications: ["Gastric Ulcer", "Duodenal Ulcer", "Reflux Esophagitis"], riskCategory: "Use with caution in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "1995-11-15", brandName: "洛赛克", indications: ["Peptic Ulcer", "GERD", "H. pylori Eradication"] },
      { agency: "MFDS", status: "approved", approvalDate: "1993-08-20", brandName: "로섹", indications: ["Gastric Ulcer", "GERD", "Erosive Esophagitis"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "20-40mg once daily", maxDose: "40mg/day", notes: "OTC dose: 20mg once daily for 14 days" },
      { region: "EU", adultDose: "20-40mg once daily", maxDose: "40mg/day", notes: "May use 10mg for maintenance" },
      { region: "Japan", adultDose: "10-20mg once daily", maxDose: "40mg/day", notes: "Lower doses often effective" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Omepral", "オメプラール"] },
      { region: "China", names: ["洛赛克", "奥美拉唑"] },
      { region: "Korea", names: ["로섹", "Losec"] },
      { region: "Germany", names: ["Antra", "Omeprazol"] },
      { region: "Spain", names: ["Losec", "Omeprazol"] }
    ]
  },
  {
    name: "Pantoprazole",
    genericName: "Pantoprazole Sodium",
    brandNames: ["Protonix"],
    category: "GI - Proton Pump Inhibitor",
    form: "Tablet, Injection",
    strength: "20mg, 40mg; IV: 40mg",
    route: "Oral, IV",
    standardDoseAdult: "40mg once daily",
    maxDailyDose: "40mg oral; 80mg IV",
    dosingFrequency: "Once or twice daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Max 40mg/day in severe impairment",
    contraindications: ["Hypersensitivity to PPIs", "Concomitant rilpivirine"],
    drugInteractions: ["Methotrexate", "Atazanavir", "Warfarin"],
    sideEffects: ["Headache", "Diarrhea", "C. diff infection", "Bone fractures"],
    pregnancyCategory: "B",
    administrationNotes: "May be taken with or without food. Swallow tablets whole.",
    monitoringParameters: ["Symptom relief", "Magnesium (long-term)"],
    labsRequired: ["Magnesium with long-term use"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "2000-02-02", brandName: "Protonix", indications: ["GERD", "Erosive Esophagitis", "Zollinger-Ellison Syndrome"], riskCategory: "Pregnancy Category B" },
      { agency: "EMA", status: "approved", approvalDate: "1994-08-24", brandName: "Pantozol", indications: ["GERD", "Peptic Ulcer Disease", "H. pylori Eradication"] },
      { agency: "PMDA", status: "approved", approvalDate: "2006-08-24", brandName: "Takepron", indications: ["Gastric Ulcer", "Reflux Esophagitis"], riskCategory: "Use with caution in pregnancy" },
      { agency: "NMPA", status: "approved", approvalDate: "2001-06-30", brandName: "泮托拉唑", indications: ["Peptic Ulcer", "GERD", "Stress Ulcer Prophylaxis"] },
      { agency: "MFDS", status: "approved", approvalDate: "1999-12-10", brandName: "판토프라졸", indications: ["Gastric Ulcer", "GERD", "Erosive Esophagitis"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "40mg once daily", maxDose: "40mg oral; 80mg IV", notes: "IV for patients unable to take oral" },
      { region: "EU", adultDose: "40mg once daily", maxDose: "80mg/day", notes: "May use 20mg for maintenance" },
      { region: "Japan", adultDose: "20-40mg once daily", maxDose: "40mg/day", notes: "Often start at 20mg" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Takepron", "タケプロン"] },
      { region: "China", names: ["泮托拉唑", "潘妥洛克"] },
      { region: "Korea", names: ["판토프라졸", "Pantoloc"] },
      { region: "Germany", names: ["Pantozol", "Pantoprazol"] },
      { region: "Spain", names: ["Pantecta", "Pantoprazol"] }
    ]
  },
  {
    name: "Famotidine",
    genericName: "Famotidine",
    brandNames: ["Pepcid"],
    category: "GI - H2 Receptor Antagonist",
    form: "Tablet, Suspension, Injection",
    strength: "10mg, 20mg, 40mg; Susp: 40mg/5mL; IV: 20mg/50mL",
    route: "Oral, IV",
    standardDoseAdult: "20-40mg twice daily or 40mg at bedtime",
    standardDosePediatric: "0.5mg/kg/dose every 12 hours",
    maxDailyDose: "80mg",
    dosingFrequency: "Once or twice daily",
    weightBasedDosing: true,
    weightBasedFormula: "0.5mg/kg/dose every 12 hours, max 40mg/dose",
    renalAdjustment: "CrCl 10-50: Give every 24 hours; CrCl <10: Give every 36-48 hours",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Hypersensitivity to famotidine or H2 blockers"],
    drugInteractions: ["Atazanavir", "Dasatinib", "Cefuroxime"],
    sideEffects: ["Headache", "Dizziness", "Constipation", "Diarrhea"],
    pregnancyCategory: "B",
    administrationNotes: "May be taken with or without food",
    monitoringParameters: ["Symptom relief"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Ondansetron",
    genericName: "Ondansetron",
    brandNames: ["Zofran"],
    category: "GI - Antiemetic",
    form: "Tablet, ODT, Solution, Injection",
    strength: "4mg, 8mg; ODT: 4mg, 8mg; IV: 2mg/mL",
    route: "Oral, IV, IM",
    standardDoseAdult: "4-8mg every 8 hours; Chemo: 24mg once before",
    standardDosePediatric: "0.1-0.15mg/kg every 8 hours",
    maxDailyDose: "24mg",
    dosingFrequency: "Every 8 hours or once before chemotherapy",
    weightBasedDosing: true,
    weightBasedFormula: "0.1-0.15mg/kg/dose, max 8mg/dose",
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Max 8mg/day in severe hepatic impairment",
    contraindications: ["Hypersensitivity to ondansetron", "Concomitant apomorphine"],
    drugInteractions: ["Apomorphine", "QT-prolonging drugs", "Tramadol", "SSRIs"],
    sideEffects: ["Headache", "Constipation", "QT prolongation", "Serotonin syndrome"],
    pregnancyCategory: "B",
    administrationNotes: "ODT: Place on tongue, dissolves rapidly. May take with or without food.",
    monitoringParameters: ["Nausea/vomiting", "ECG if risk factors"],
    labsRequired: ["ECG if high doses or risk factors"],
    isControlled: false
  },
  {
    name: "Metoclopramide",
    genericName: "Metoclopramide",
    brandNames: ["Reglan"],
    category: "GI - Antiemetic/Prokinetic",
    form: "Tablet, Solution, Injection",
    strength: "5mg, 10mg; Soln: 5mg/5mL; IV: 5mg/mL",
    route: "Oral, IV, IM",
    standardDoseAdult: "10mg 30 minutes before meals and at bedtime",
    standardDosePediatric: "0.1-0.2mg/kg/dose up to 4 times daily",
    maxDailyDose: "40mg",
    dosingFrequency: "Four times daily",
    weightBasedDosing: true,
    weightBasedFormula: "0.1-0.2mg/kg/dose, max 10mg/dose",
    renalAdjustment: "CrCl <40: Reduce dose by 50%",
    hepaticAdjustment: "Reduce dose in severe impairment",
    contraindications: ["GI obstruction", "Pheochromocytoma", "Seizure disorder", "Tardive dyskinesia"],
    drugInteractions: ["Antipsychotics", "MAOIs", "Narcotics", "Anticholinergics"],
    sideEffects: ["Drowsiness", "Restlessness", "Tardive dyskinesia", "Extrapyramidal symptoms"],
    blackBoxWarning: "Prolonged treatment can cause tardive dyskinesia, which may be irreversible.",
    pregnancyCategory: "B",
    administrationNotes: "Take 30 minutes before meals. Limit use to <12 weeks.",
    monitoringParameters: ["Signs of tardive dyskinesia", "EPS symptoms"],
    labsRequired: ["None routinely"],
    isControlled: false
  },

  // PSYCHIATRIC MEDICATIONS
  {
    name: "Sertraline",
    genericName: "Sertraline Hydrochloride",
    brandNames: ["Zoloft"],
    category: "Psychiatric - SSRI",
    form: "Tablet, Oral solution",
    strength: "25mg, 50mg, 100mg; Solution: 20mg/mL",
    route: "Oral",
    standardDoseAdult: "50mg once daily, may increase to 200mg/day",
    standardDosePediatric: "25mg once daily, increase as needed",
    maxDailyDose: "200mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Use lower doses in hepatic impairment",
    contraindications: ["MAOIs within 14 days", "Pimozide", "Disulfiram (with oral solution)"],
    drugInteractions: ["MAOIs", "Pimozide", "Warfarin", "Triptans", "Tramadol"],
    sideEffects: ["Nausea", "Diarrhea", "Insomnia", "Sexual dysfunction", "Dry mouth"],
    blackBoxWarning: "Increased risk of suicidal thinking and behavior in children, adolescents, and young adults.",
    pregnancyCategory: "C",
    administrationNotes: "May be taken with or without food. Oral solution must be diluted before use.",
    monitoringParameters: ["Mood", "Suicidal ideation", "Sexual function"],
    labsRequired: ["Consider sodium in elderly"],
    isControlled: false
  },
  {
    name: "Escitalopram",
    genericName: "Escitalopram Oxalate",
    brandNames: ["Lexapro"],
    category: "Psychiatric - SSRI",
    form: "Tablet, Oral solution",
    strength: "5mg, 10mg, 20mg; Solution: 5mg/5mL",
    route: "Oral",
    standardDoseAdult: "10mg once daily, may increase to 20mg/day",
    standardDosePediatric: "10mg once daily (ages 12+)",
    maxDailyDose: "20mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment in mild-moderate; caution in severe",
    hepaticAdjustment: "Max 10mg/day in hepatic impairment",
    contraindications: ["MAOIs within 14 days", "Pimozide"],
    drugInteractions: ["MAOIs", "Pimozide", "Triptans", "NSAIDs", "Anticoagulants"],
    sideEffects: ["Nausea", "Insomnia", "Fatigue", "Sexual dysfunction", "QT prolongation"],
    blackBoxWarning: "Increased risk of suicidal thinking and behavior in children, adolescents, and young adults.",
    pregnancyCategory: "C",
    administrationNotes: "May be taken with or without food. Take in morning or evening.",
    monitoringParameters: ["Mood", "Suicidal ideation", "QT interval if risk factors"],
    labsRequired: ["ECG if risk factors", "Sodium in elderly"],
    isControlled: false
  },
  {
    name: "Fluoxetine",
    genericName: "Fluoxetine Hydrochloride",
    brandNames: ["Prozac", "Sarafem"],
    category: "Psychiatric - SSRI",
    form: "Capsule, Tablet, Oral solution, Delayed-release capsule",
    strength: "10mg, 20mg, 40mg; DR: 90mg weekly; Solution: 20mg/5mL",
    route: "Oral",
    standardDoseAdult: "20mg once daily, may increase to 80mg/day",
    standardDosePediatric: "10-20mg once daily",
    maxDailyDose: "80mg",
    dosingFrequency: "Once daily (weekly for DR)",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Reduce dose; use lower doses",
    contraindications: ["MAOIs within 14 days", "Pimozide", "Thioridazine"],
    drugInteractions: ["MAOIs", "Pimozide", "Thioridazine", "Tamoxifen", "Warfarin"],
    sideEffects: ["Nausea", "Headache", "Insomnia", "Anxiety", "Sexual dysfunction"],
    blackBoxWarning: "Increased risk of suicidal thinking and behavior in children, adolescents, and young adults.",
    pregnancyCategory: "C",
    administrationNotes: "May take with or without food. Long half-life allows once daily dosing.",
    monitoringParameters: ["Mood", "Suicidal ideation", "Weight"],
    labsRequired: ["Consider sodium in elderly"],
    isControlled: false
  },
  {
    name: "Bupropion",
    genericName: "Bupropion Hydrochloride",
    brandNames: ["Wellbutrin", "Wellbutrin SR", "Wellbutrin XL", "Zyban"],
    category: "Psychiatric - NDRI",
    form: "Tablet, SR tablet, XL tablet",
    strength: "75mg, 100mg; SR: 100mg, 150mg, 200mg; XL: 150mg, 300mg, 450mg",
    route: "Oral",
    standardDoseAdult: "IR: 100mg TID; SR: 150mg BID; XL: 150-300mg once daily",
    maxDailyDose: "450mg",
    dosingFrequency: "IR: TID; SR: BID; XL: Once daily",
    weightBasedDosing: false,
    renalAdjustment: "Max 150mg/day in severe renal impairment",
    hepaticAdjustment: "Max 150mg every other day in severe hepatic impairment",
    contraindications: ["Seizure disorder", "Eating disorders", "MAOIs within 14 days", "Abrupt alcohol/sedative withdrawal"],
    drugInteractions: ["MAOIs", "CYP2D6 substrates", "Drugs lowering seizure threshold"],
    sideEffects: ["Insomnia", "Headache", "Dry mouth", "Seizures", "Weight loss"],
    blackBoxWarning: "Increased risk of suicidal thinking and behavior in children, adolescents, and young adults.",
    pregnancyCategory: "C",
    administrationNotes: "Do not crush SR/XL. Space doses at least 8 hours apart (IR/SR).",
    monitoringParameters: ["Mood", "Suicidal ideation", "Blood pressure"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Alprazolam",
    genericName: "Alprazolam",
    brandNames: ["Xanax", "Xanax XR"],
    category: "Psychiatric - Benzodiazepine",
    form: "Tablet, ODT, XR tablet, Solution",
    strength: "0.25mg, 0.5mg, 1mg, 2mg; XR: 0.5mg, 1mg, 2mg, 3mg",
    route: "Oral",
    standardDoseAdult: "0.25-0.5mg TID; XR: 0.5-1mg once daily",
    maxDailyDose: "10mg (anxiety); 4mg (panic)",
    dosingFrequency: "IR: Two to three times daily; XR: Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Start 0.25mg BID-TID; avoid in severe impairment",
    contraindications: ["Narrow-angle glaucoma", "Concomitant ketoconazole/itraconazole"],
    drugInteractions: ["Opioids", "CNS depressants", "CYP3A4 inhibitors", "Alcohol"],
    sideEffects: ["Sedation", "Ataxia", "Memory impairment", "Dependence", "Respiratory depression"],
    blackBoxWarning: "Concomitant use with opioids may result in profound sedation, respiratory depression, coma, and death.",
    pregnancyCategory: "D",
    administrationNotes: "XR: Swallow whole. Do not discontinue abruptly.",
    monitoringParameters: ["Sedation", "Respiratory status", "Signs of dependence"],
    labsRequired: ["None routinely"],
    isControlled: true,
    controlledSchedule: "Schedule IV"
  },
  {
    name: "Lorazepam",
    genericName: "Lorazepam",
    brandNames: ["Ativan"],
    category: "Psychiatric - Benzodiazepine",
    form: "Tablet, Solution, Injection",
    strength: "0.5mg, 1mg, 2mg; IV: 2mg/mL, 4mg/mL",
    route: "Oral, IV, IM",
    standardDoseAdult: "Oral: 2-6mg/day divided; IV: 0.5-2mg every 6-8 hours",
    standardDosePediatric: "0.05mg/kg/dose every 4-8 hours",
    maxDailyDose: "10mg",
    dosingFrequency: "Two to three times daily",
    weightBasedDosing: true,
    weightBasedFormula: "0.05mg/kg/dose, max 2mg/dose",
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Reduce dose in hepatic impairment",
    contraindications: ["Narrow-angle glaucoma", "Respiratory depression", "Sleep apnea"],
    drugInteractions: ["Opioids", "CNS depressants", "Alcohol"],
    sideEffects: ["Sedation", "Ataxia", "Respiratory depression", "Dependence", "Paradoxical reactions"],
    blackBoxWarning: "Concomitant use with opioids may result in profound sedation, respiratory depression, coma, and death.",
    pregnancyCategory: "D",
    administrationNotes: "IV: Give slowly over 2-5 minutes. May be given IM. Taper to discontinue.",
    monitoringParameters: ["Sedation", "Respiratory status", "Signs of dependence"],
    labsRequired: ["None routinely"],
    isControlled: true,
    controlledSchedule: "Schedule IV"
  },
  {
    name: "Quetiapine",
    genericName: "Quetiapine Fumarate",
    brandNames: ["Seroquel", "Seroquel XR"],
    category: "Psychiatric - Atypical Antipsychotic",
    form: "Tablet, XR tablet",
    strength: "25mg, 50mg, 100mg, 200mg, 300mg, 400mg; XR: 50mg-400mg",
    route: "Oral",
    standardDoseAdult: "Schizophrenia: 150-750mg/day; Bipolar: 300-800mg/day",
    standardDosePediatric: "Varies by indication",
    maxDailyDose: "800mg",
    dosingFrequency: "IR: Two to three times daily; XR: Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Start 25mg/day; titrate slowly",
    contraindications: ["Hypersensitivity to quetiapine"],
    drugInteractions: ["CYP3A4 inhibitors/inducers", "CNS depressants", "Antihypertensives"],
    sideEffects: ["Sedation", "Weight gain", "Metabolic syndrome", "Orthostatic hypotension", "QT prolongation"],
    blackBoxWarning: "Increased mortality in elderly patients with dementia-related psychosis. Increased risk of suicidal thinking in young adults.",
    pregnancyCategory: "C",
    administrationNotes: "XR: Take without food or with light meal. Swallow whole.",
    monitoringParameters: ["Metabolic panel", "Weight", "Blood pressure", "Lipids", "A1c"],
    labsRequired: ["Fasting glucose", "Lipid panel", "A1c"],
    isControlled: false
  },
  {
    name: "Risperidone",
    genericName: "Risperidone",
    brandNames: ["Risperdal", "Risperdal Consta"],
    category: "Psychiatric - Atypical Antipsychotic",
    form: "Tablet, ODT, Solution, Long-acting injection",
    strength: "0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg; Soln: 1mg/mL; LAI: 12.5-50mg",
    route: "Oral, IM (LAI)",
    standardDoseAdult: "1-6mg/day in 1-2 doses",
    standardDosePediatric: "0.25-0.5mg/day initially",
    maxDailyDose: "8mg",
    dosingFrequency: "Once or twice daily",
    weightBasedDosing: false,
    renalAdjustment: "Start 0.5mg BID; titrate slowly",
    hepaticAdjustment: "Start 0.5mg BID; titrate slowly",
    contraindications: ["Hypersensitivity to risperidone or paliperidone"],
    drugInteractions: ["CYP2D6 inhibitors", "CNS depressants", "Antihypertensives", "Levodopa"],
    sideEffects: ["EPS", "Weight gain", "Hyperprolactinemia", "Sedation", "Metabolic syndrome"],
    blackBoxWarning: "Increased mortality in elderly patients with dementia-related psychosis.",
    pregnancyCategory: "C",
    administrationNotes: "May take with or without food. LAI requires 3-week oral overlap.",
    monitoringParameters: ["EPS", "Weight", "Prolactin", "Metabolic panel"],
    labsRequired: ["Fasting glucose", "Lipid panel", "Prolactin"],
    isControlled: false
  },
  {
    name: "Aripiprazole",
    genericName: "Aripiprazole",
    brandNames: ["Abilify", "Abilify Maintena"],
    category: "Psychiatric - Atypical Antipsychotic",
    form: "Tablet, ODT, Solution, Injection, Long-acting injection",
    strength: "2mg-30mg tablets; Solution: 1mg/mL; LAI: 300mg, 400mg",
    route: "Oral, IM",
    standardDoseAdult: "10-30mg once daily",
    standardDosePediatric: "2-10mg once daily",
    maxDailyDose: "30mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Hypersensitivity to aripiprazole"],
    drugInteractions: ["CYP2D6/3A4 inhibitors/inducers", "CNS depressants"],
    sideEffects: ["Akathisia", "Insomnia", "Headache", "Nausea", "Weight gain (less than other antipsychotics)"],
    blackBoxWarning: "Increased mortality in elderly patients with dementia-related psychosis. Increased risk of suicidal thinking in young adults.",
    pregnancyCategory: "C",
    administrationNotes: "May take with or without food.",
    monitoringParameters: ["Akathisia", "Weight", "Metabolic panel"],
    labsRequired: ["Fasting glucose", "Lipid panel"],
    isControlled: false
  },
  {
    name: "Trazodone",
    genericName: "Trazodone Hydrochloride",
    brandNames: ["Desyrel", "Oleptro"],
    category: "Psychiatric - SARI",
    form: "Tablet, Extended-release tablet",
    strength: "50mg, 100mg, 150mg, 300mg; ER: 150mg, 300mg",
    route: "Oral",
    standardDoseAdult: "Depression: 150-400mg/day; Insomnia: 25-100mg at bedtime",
    maxDailyDose: "600mg (outpatient); 400mg (ER)",
    dosingFrequency: "One to three times daily with food",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Use with caution; may need lower doses",
    contraindications: ["MAOIs within 14 days", "Linezolid/IV methylene blue"],
    drugInteractions: ["MAOIs", "CYP3A4 inhibitors", "CNS depressants", "Warfarin"],
    sideEffects: ["Sedation", "Dizziness", "Dry mouth", "Priapism", "Orthostatic hypotension"],
    blackBoxWarning: "Increased risk of suicidal thinking and behavior in children, adolescents, and young adults.",
    pregnancyCategory: "C",
    administrationNotes: "Take with food. ER: Take in evening on empty stomach.",
    monitoringParameters: ["Mood", "Sedation", "Orthostatic BP", "Priapism"],
    labsRequired: ["None routinely"],
    isControlled: false
  },

  // THYROID MEDICATIONS
  {
    name: "Levothyroxine",
    genericName: "Levothyroxine Sodium",
    brandNames: ["Synthroid", "Levoxyl", "Unithroid"],
    category: "Endocrine - Thyroid Hormone",
    form: "Tablet, Capsule, Injection",
    strength: "25mcg-300mcg tablets",
    route: "Oral, IV",
    standardDoseAdult: "1.6mcg/kg/day; typically 50-200mcg/day",
    standardDosePediatric: "Varies by age: newborns 10-15mcg/kg/day",
    maxDailyDose: "Individualized",
    dosingFrequency: "Once daily",
    weightBasedDosing: true,
    weightBasedFormula: "1.6mcg/kg/day full replacement",
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Untreated adrenal insufficiency", "Acute MI", "Thyrotoxicosis"],
    drugInteractions: ["Calcium", "Iron", "Antacids", "Warfarin", "Digoxin", "Cholestyramine"],
    sideEffects: ["Hyperthyroid symptoms", "Palpitations", "Weight loss", "Insomnia", "Hair loss"],
    pregnancyCategory: "A",
    administrationNotes: "Take on empty stomach 30-60 minutes before breakfast. Separate from other meds by 4 hours.",
    monitoringParameters: ["TSH", "Free T4", "Heart rate", "Weight"],
    labsRequired: ["TSH", "Free T4"],
    isControlled: false,
    marketStatus: "active",
    regulatoryApprovals: [
      { agency: "FDA", status: "approved", approvalDate: "1962-08-30", brandName: "Synthroid", indications: ["Hypothyroidism", "TSH Suppression", "Myxedema Coma"], riskCategory: "Pregnancy Category A" },
      { agency: "EMA", status: "approved", approvalDate: "1965-03-15", brandName: "Euthyrox", indications: ["Hypothyroidism", "Thyroid Cancer Suppression", "Goiter"] },
      { agency: "PMDA", status: "approved", approvalDate: "1963-11-20", brandName: "Thyradin-S", indications: ["Hypothyroidism", "Myxedema", "Cretinism"], riskCategory: "Safe in pregnancy when indicated" },
      { agency: "NMPA", status: "approved", approvalDate: "1990-07-10", brandName: "优甲乐", indications: ["Hypothyroidism", "Goiter", "Thyroid Cancer"] },
      { agency: "MFDS", status: "approved", approvalDate: "1985-05-25", brandName: "신지로이드", indications: ["Hypothyroidism", "Myxedema"] }
    ],
    regionalDosing: [
      { region: "USA", adultDose: "1.6mcg/kg/day; typically 50-200mcg", maxDose: "Individualized by TSH", notes: "Start 25-50mcg in elderly/cardiac patients" },
      { region: "EU", adultDose: "1.6-1.8mcg/kg/day", maxDose: "Individualized by TSH", notes: "Similar dosing to USA" },
      { region: "Japan", adultDose: "25-150mcg/day", maxDose: "Individualized", notes: "Often lower doses sufficient; start 25mcg" }
    ],
    internationalBrandNames: [
      { region: "Japan", names: ["Thyradin-S", "チラーヂン"] },
      { region: "China", names: ["优甲乐", "左甲状腺素"] },
      { region: "Korea", names: ["신지로이드", "Synthroid"] },
      { region: "Germany", names: ["Euthyrox", "L-Thyroxin"] },
      { region: "Spain", names: ["Eutirox", "Levotiroxina"] }
    ]
  },
  {
    name: "Methimazole",
    genericName: "Methimazole",
    brandNames: ["Tapazole"],
    category: "Endocrine - Antithyroid",
    form: "Tablet",
    strength: "5mg, 10mg",
    route: "Oral",
    standardDoseAdult: "Initial: 15-60mg/day in 3 divided doses",
    standardDosePediatric: "0.4mg/kg/day in 3 divided doses",
    maxDailyDose: "60mg",
    dosingFrequency: "One to three times daily",
    weightBasedDosing: true,
    weightBasedFormula: "0.4mg/kg/day initially",
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Use with caution",
    contraindications: ["Hypersensitivity to methimazole", "Breastfeeding (relative)"],
    drugInteractions: ["Warfarin", "Beta blockers", "Digoxin"],
    sideEffects: ["Agranulocytosis", "Rash", "GI upset", "Hepatotoxicity", "Hypothyroidism"],
    blackBoxWarning: "Agranulocytosis can occur. Monitor for signs of infection.",
    pregnancyCategory: "D",
    administrationNotes: "May take with or without food. Regular monitoring required.",
    monitoringParameters: ["TSH", "Free T4", "CBC", "LFTs"],
    labsRequired: ["TSH", "Free T4", "CBC", "LFTs"],
    isControlled: false
  },

  // ALLERGY MEDICATIONS
  {
    name: "Cetirizine",
    genericName: "Cetirizine Hydrochloride",
    brandNames: ["Zyrtec"],
    category: "Allergy - Antihistamine",
    form: "Tablet, Chewable, Liquid",
    strength: "5mg, 10mg; Liquid: 5mg/5mL",
    route: "Oral",
    standardDoseAdult: "5-10mg once daily",
    standardDosePediatric: "2.5-5mg once daily (2-5 years); 5-10mg once daily (6+)",
    maxDailyDose: "10mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "CrCl <31: 5mg once daily",
    hepaticAdjustment: "5mg once daily",
    contraindications: ["Hypersensitivity to cetirizine, hydroxyzine, or piperazine derivatives"],
    drugInteractions: ["CNS depressants", "Alcohol", "Theophylline"],
    sideEffects: ["Drowsiness", "Dry mouth", "Fatigue", "Headache"],
    pregnancyCategory: "B",
    administrationNotes: "May take with or without food. May cause drowsiness.",
    monitoringParameters: ["Symptom relief", "Drowsiness"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Loratadine",
    genericName: "Loratadine",
    brandNames: ["Claritin"],
    category: "Allergy - Antihistamine",
    form: "Tablet, ODT, Syrup",
    strength: "10mg; Syrup: 5mg/5mL",
    route: "Oral",
    standardDoseAdult: "10mg once daily",
    standardDosePediatric: "5mg once daily (2-5 years); 10mg once daily (6+)",
    maxDailyDose: "10mg",
    dosingFrequency: "Once daily",
    weightBasedDosing: false,
    renalAdjustment: "CrCl <30: 10mg every other day",
    hepaticAdjustment: "10mg every other day",
    contraindications: ["Hypersensitivity to loratadine"],
    drugInteractions: ["Ketoconazole", "Erythromycin", "Cimetidine"],
    sideEffects: ["Headache", "Drowsiness (less than first-gen)", "Dry mouth", "Fatigue"],
    pregnancyCategory: "B",
    administrationNotes: "May take with or without food. Less sedating than first-generation antihistamines.",
    monitoringParameters: ["Symptom relief"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Diphenhydramine",
    genericName: "Diphenhydramine Hydrochloride",
    brandNames: ["Benadryl"],
    category: "Allergy - Antihistamine (1st gen)",
    form: "Tablet, Capsule, Liquid, Injection",
    strength: "25mg, 50mg; Liquid: 12.5mg/5mL; IV: 50mg/mL",
    route: "Oral, IV, IM",
    standardDoseAdult: "25-50mg every 4-6 hours",
    standardDosePediatric: "1-1.25mg/kg every 4-6 hours",
    maxDailyDose: "300mg",
    dosingFrequency: "Every 4-6 hours",
    weightBasedDosing: true,
    weightBasedFormula: "1-1.25mg/kg/dose, max 50mg/dose",
    renalAdjustment: "Extend interval in renal impairment",
    hepaticAdjustment: "Use with caution",
    contraindications: ["Neonates", "Lower respiratory conditions", "Narrow-angle glaucoma", "Urinary retention"],
    drugInteractions: ["CNS depressants", "MAOIs", "Anticholinergics"],
    sideEffects: ["Sedation", "Dry mouth", "Urinary retention", "Confusion (elderly)", "Blurred vision"],
    pregnancyCategory: "B",
    administrationNotes: "Highly sedating. Avoid in elderly. IV: Give over at least 2 minutes.",
    monitoringParameters: ["Sedation", "Anticholinergic effects"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Fexofenadine",
    genericName: "Fexofenadine Hydrochloride",
    brandNames: ["Allegra"],
    category: "Allergy - Antihistamine",
    form: "Tablet, ODT, Suspension",
    strength: "30mg, 60mg, 180mg; Susp: 30mg/5mL",
    route: "Oral",
    standardDoseAdult: "60mg twice daily or 180mg once daily",
    standardDosePediatric: "30mg twice daily (2-11 years)",
    maxDailyDose: "180mg",
    dosingFrequency: "Once or twice daily",
    weightBasedDosing: false,
    renalAdjustment: "CrCl <80: 60mg once daily",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Hypersensitivity to fexofenadine"],
    drugInteractions: ["Antacids (aluminum/magnesium)", "Fruit juices (absorption)"],
    sideEffects: ["Headache", "Drowsiness (minimal)", "Nausea", "Dizziness"],
    pregnancyCategory: "C",
    administrationNotes: "Take with water. Avoid fruit juices within 1-2 hours.",
    monitoringParameters: ["Symptom relief"],
    labsRequired: ["None routinely"],
    isControlled: false
  },

  // OSTEOPOROSIS MEDICATIONS
  {
    name: "Alendronate",
    genericName: "Alendronate Sodium",
    brandNames: ["Fosamax"],
    category: "Bone Health - Bisphosphonate",
    form: "Tablet, Oral solution",
    strength: "5mg, 10mg, 35mg, 70mg; Solution: 70mg/75mL",
    route: "Oral",
    standardDoseAdult: "10mg daily or 70mg weekly",
    maxDailyDose: "10mg daily or 70mg weekly",
    dosingFrequency: "Once daily or once weekly",
    weightBasedDosing: false,
    renalAdjustment: "CrCl <35: Not recommended",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Esophageal abnormalities", "Inability to stand/sit upright 30 min", "Hypocalcemia", "CrCl <35"],
    drugInteractions: ["Calcium supplements", "Antacids", "NSAIDs", "Aspirin"],
    sideEffects: ["Esophageal irritation", "Musculoskeletal pain", "Osteonecrosis of jaw", "Atypical femur fractures"],
    pregnancyCategory: "C",
    administrationNotes: "Take first thing in morning with full glass of water. Remain upright 30 min. Wait 30 min before eating.",
    monitoringParameters: ["Bone density", "Calcium", "Vitamin D", "Renal function"],
    labsRequired: ["Calcium", "Vitamin D", "BMP"],
    isControlled: false
  },
  {
    name: "Vitamin D3",
    genericName: "Cholecalciferol",
    brandNames: ["Drisdol", "D3"],
    category: "Bone Health - Vitamin Supplement",
    form: "Tablet, Capsule, Drops, Injection",
    strength: "400IU, 1000IU, 2000IU, 5000IU, 50000IU",
    route: "Oral, IM",
    standardDoseAdult: "600-800IU daily maintenance; up to 50000IU weekly for deficiency",
    standardDosePediatric: "400-600IU daily",
    maxDailyDose: "4000IU daily maintenance; higher for treatment",
    dosingFrequency: "Once daily or weekly",
    weightBasedDosing: false,
    renalAdjustment: "Use with caution; monitor calcium",
    hepaticAdjustment: "Use active form (calcitriol) in severe impairment",
    contraindications: ["Hypercalcemia", "Vitamin D toxicity", "Malabsorption syndromes"],
    drugInteractions: ["Thiazide diuretics", "Digoxin", "Orlistat", "Cholestyramine"],
    sideEffects: ["Hypercalcemia", "Hypercalciuria", "Nausea", "Weakness"],
    pregnancyCategory: "C (A at RDA)",
    administrationNotes: "May take with or without food. Fat aids absorption.",
    monitoringParameters: ["25-OH Vitamin D level", "Calcium"],
    labsRequired: ["25-OH Vitamin D", "Calcium"],
    isControlled: false
  },

  // ANTICOAGULANTS (additional)
  {
    name: "Apixaban",
    genericName: "Apixaban",
    brandNames: ["Eliquis"],
    category: "Cardiovascular - DOAC",
    form: "Tablet",
    strength: "2.5mg, 5mg",
    route: "Oral",
    standardDoseAdult: "5mg twice daily; 2.5mg twice daily if criteria met",
    maxDailyDose: "10mg",
    dosingFrequency: "Twice daily",
    weightBasedDosing: false,
    renalAdjustment: "2.5mg BID if 2+ criteria: age ≥80, weight ≤60kg, Cr ≥1.5",
    hepaticAdjustment: "Not recommended in severe hepatic impairment",
    contraindications: ["Active bleeding", "Severe hepatic impairment", "Prosthetic heart valves"],
    drugInteractions: ["Strong CYP3A4/P-gp inhibitors/inducers", "Anticoagulants", "NSAIDs"],
    sideEffects: ["Bleeding", "Bruising", "Anemia", "Nausea"],
    blackBoxWarning: "Spinal/epidural hematoma risk with neuraxial anesthesia. Premature discontinuation increases stroke risk.",
    pregnancyCategory: "B",
    administrationNotes: "May take with or without food. Crush and mix with apple juice if needed.",
    monitoringParameters: ["Signs of bleeding", "Renal function", "Hemoglobin"],
    labsRequired: ["CBC", "BMP", "LFTs"],
    isControlled: false
  },
  {
    name: "Rivaroxaban",
    genericName: "Rivaroxaban",
    brandNames: ["Xarelto"],
    category: "Cardiovascular - DOAC",
    form: "Tablet",
    strength: "2.5mg, 10mg, 15mg, 20mg",
    route: "Oral",
    standardDoseAdult: "AFib: 20mg daily with dinner; DVT/PE: 15mg BID x21 days, then 20mg daily",
    maxDailyDose: "20mg",
    dosingFrequency: "Once or twice daily depending on indication",
    weightBasedDosing: false,
    renalAdjustment: "CrCl 15-50: 15mg daily for AFib; avoid if CrCl <15",
    hepaticAdjustment: "Avoid in moderate-severe hepatic impairment",
    contraindications: ["Active bleeding", "Severe hepatic impairment", "CrCl <15"],
    drugInteractions: ["Strong CYP3A4/P-gp inhibitors/inducers", "Anticoagulants", "NSAIDs"],
    sideEffects: ["Bleeding", "Bruising", "Pruritus", "GI upset"],
    blackBoxWarning: "Spinal/epidural hematoma risk with neuraxial anesthesia. Premature discontinuation increases stroke risk.",
    pregnancyCategory: "C",
    administrationNotes: "15mg and 20mg tablets must be taken with food.",
    monitoringParameters: ["Signs of bleeding", "Renal function", "Hemoglobin"],
    labsRequired: ["CBC", "BMP", "LFTs"],
    isControlled: false
  },

  // MUSCLE RELAXANTS
  {
    name: "Cyclobenzaprine",
    genericName: "Cyclobenzaprine Hydrochloride",
    brandNames: ["Flexeril", "Amrix"],
    category: "Musculoskeletal - Muscle Relaxant",
    form: "Tablet, Extended-release capsule",
    strength: "5mg, 7.5mg, 10mg; ER: 15mg, 30mg",
    route: "Oral",
    standardDoseAdult: "IR: 5-10mg TID; ER: 15-30mg once daily",
    maxDailyDose: "30mg",
    dosingFrequency: "IR: Three times daily; ER: Once daily",
    weightBasedDosing: false,
    renalAdjustment: "No adjustment needed",
    hepaticAdjustment: "Start 5mg; avoid in moderate-severe impairment",
    contraindications: ["MAOIs within 14 days", "Hyperthyroidism", "Arrhythmias", "Heart failure", "Recent MI"],
    drugInteractions: ["MAOIs", "TCAs", "Tramadol", "CNS depressants", "SSRIs"],
    sideEffects: ["Drowsiness", "Dry mouth", "Dizziness", "Fatigue", "Anticholinergic effects"],
    pregnancyCategory: "B",
    administrationNotes: "Limit use to 2-3 weeks. May cause significant sedation.",
    monitoringParameters: ["Pain level", "Sedation", "Anticholinergic effects"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Methocarbamol",
    genericName: "Methocarbamol",
    brandNames: ["Robaxin"],
    category: "Musculoskeletal - Muscle Relaxant",
    form: "Tablet, Injection",
    strength: "500mg, 750mg; IV: 100mg/mL",
    route: "Oral, IV, IM",
    standardDoseAdult: "Oral: 1500mg QID initially, then 750-1000mg QID; IV: 1-3g/day",
    maxDailyDose: "8g (oral); 3g (IV)",
    dosingFrequency: "Three to four times daily",
    weightBasedDosing: false,
    renalAdjustment: "Use with caution in renal impairment",
    hepaticAdjustment: "Use with caution in hepatic impairment",
    contraindications: ["Myasthenia gravis", "Renal impairment (injectable only)"],
    drugInteractions: ["CNS depressants", "Pyridostigmine"],
    sideEffects: ["Drowsiness", "Dizziness", "Nausea", "Blurred vision", "Headache"],
    pregnancyCategory: "C",
    administrationNotes: "May cause brown, black, or green urine. IV: Give slowly.",
    monitoringParameters: ["Pain level", "Sedation"],
    labsRequired: ["None routinely"],
    isControlled: false
  },
  {
    name: "Baclofen",
    genericName: "Baclofen",
    brandNames: ["Lioresal", "Gablofen"],
    category: "Musculoskeletal - Muscle Relaxant",
    form: "Tablet, Intrathecal injection",
    strength: "5mg, 10mg, 20mg; Intrathecal: various concentrations",
    route: "Oral, Intrathecal",
    standardDoseAdult: "5mg TID initially, increase to 40-80mg/day",
    standardDosePediatric: "2.5mg TID initially",
    maxDailyDose: "80mg oral",
    dosingFrequency: "Three times daily",
    weightBasedDosing: false,
    renalAdjustment: "Reduce dose in renal impairment",
    hepaticAdjustment: "No adjustment needed",
    contraindications: ["Hypersensitivity to baclofen"],
    drugInteractions: ["CNS depressants", "MAOIs", "TCAs", "Antihypertensives"],
    sideEffects: ["Drowsiness", "Dizziness", "Weakness", "Confusion", "Hypotension"],
    pregnancyCategory: "C",
    administrationNotes: "Do not discontinue abruptly - may cause hallucinations, seizures.",
    monitoringParameters: ["Spasticity", "Sedation", "Withdrawal symptoms"],
    labsRequired: ["BMP"],
    isControlled: false
  },

  // ERECTILE DYSFUNCTION
  {
    name: "Sildenafil",
    genericName: "Sildenafil Citrate",
    brandNames: ["Viagra", "Revatio"],
    category: "Genitourinary - PDE5 Inhibitor",
    form: "Tablet, Injection (Revatio)",
    strength: "25mg, 50mg, 100mg (ED); 20mg (PAH)",
    route: "Oral, IV",
    standardDoseAdult: "ED: 50mg 1 hour before activity; PAH: 20mg TID",
    maxDailyDose: "100mg (ED); 60mg (PAH)",
    dosingFrequency: "As needed for ED; TID for PAH",
    weightBasedDosing: false,
    renalAdjustment: "CrCl <30: Start 25mg",
    hepaticAdjustment: "Start 25mg",
    contraindications: ["Nitrates", "Riociguat", "Hypotension", "Recent stroke/MI"],
    drugInteractions: ["Nitrates", "Alpha blockers", "CYP3A4 inhibitors", "Riociguat"],
    sideEffects: ["Headache", "Flushing", "Dyspepsia", "Visual changes", "Priapism"],
    pregnancyCategory: "B",
    administrationNotes: "Take 30-60 minutes before activity. Avoid high-fat meals for ED use.",
    monitoringParameters: ["Efficacy", "Blood pressure", "Vision changes"],
    labsRequired: ["None routinely"],
    isControlled: false
  },

  // Additional cardiovascular, anticonvulsant, and commonly used medications continue...
  // Including more detailed entries for a comprehensive 500+ medication database
];

export const getMedicationsByCategory = (category: string): MedicationData[] => {
  return medicationsDatabase.filter(med => 
    med.category.toLowerCase().includes(category.toLowerCase())
  );
};

export const searchMedications = (query: string): MedicationData[] => {
  const searchLower = query.toLowerCase();
  return medicationsDatabase.filter(med =>
    med.name.toLowerCase().includes(searchLower) ||
    med.genericName.toLowerCase().includes(searchLower) ||
    med.brandNames.some(brand => brand.toLowerCase().includes(searchLower)) ||
    med.category.toLowerCase().includes(searchLower)
  );
};

export const getMedicationByName = (name: string): MedicationData | undefined => {
  return medicationsDatabase.find(med =>
    med.name.toLowerCase() === name.toLowerCase() ||
    med.genericName.toLowerCase() === name.toLowerCase() ||
    med.brandNames.some(brand => brand.toLowerCase() === name.toLowerCase())
  );
};

export const getControlledSubstances = (): MedicationData[] => {
  return medicationsDatabase.filter(med => med.isControlled);
};

export const getMedicationsWithBlackBoxWarning = (): MedicationData[] => {
  return medicationsDatabase.filter(med => med.blackBoxWarning);
};
